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Abstract

DIABETES SHARED MEDICAL APPOINTMENT: AN EVIDENCE-BASED INNOVATION
PROJECT
Mohamed Bojang
Dissertation Chair: Sandra Petersen, DNP
The University of Texas at Tyler
May 2019

The purpose of the EPIP project is to address uncontrolled diabetes by implementing an
evidence-based shared medical appointment (SMA) intervention which based on the body of the
evidence will help improve diabetes outcomes. A pilot implementation and retrospective chart
review were conducted. Data was collected on outcome indicators such as blood pressure, lipid
values, body mass index, A1C, and knowledge. The results of a pilot SMA implementation
revealed that patients who participated in the weekly SMA saw an improvement in post-mean
values compared to pre-mean values. Mean A1c dropped to 7.0% from 7.11%; systolic blood
pressure improved to125 mmHg from 128 mmHg; diastolic blood pressure dropped to 77 mmHg
from 84 mmHg; body mass index dropped to 33.63 kg/m2 from 35.44 kg/m2; and, knowledge
increased from 52% to 93%. Retrospective chart review findings revealed that the number of
patients who were at goal A1C increased from 25% to 38% post intervention. The number of
patients at goal for hypertension increased from 65% to 88%, and mean HbA1c dropped from
8.0% to 7.5%. These findings are consistent with those represented in the body of the evidence,
suggesting SMA as an effective and feasible intervention to helping diabetes patients to meet
glycemic goals and improving diabetes outcomes. Therefore, policy and culture change are
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warranted to adopt and sustain SMA as the standard of diabetes care. New clinic policies, SMA
clinic mentors, and utilization of conceptual models will promote sustainability of SMA.
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Chapter 1
Development of Clinical Question and Problem Identification (EBP Steps 0, 1, & 2)
Background and Significance
Diabetes is currently affecting 422 million people globally; this is a rise of 314 million
people since 1980 (World Health Organization (WHO), 2018). The global prevalence of diabetes
among adults over the age of 18 years has risen from 4.7% in 1980 to 8.5% in 2014 (WHO,
2018). The prevalence has been rising more rapidly in middle and low-income countries (WHO,
2018). In the United States (US), diabetes is currently affecting 30.3 million Americans or 9.4%
of the US population; out of this number, 23.1 million have been diagnosed and 7.2 million have
the disease but are yet to be diagnosed (Centers for Disease Control and Prevention (CDC),
2017).
Some of the common and serious complications of diabetes include cardiovascular and
chronic kidney diseases. In 2014, a total of 7.2 million hospital discharges with diabetes as the
diagnosis were reported in the US; out of these number, 1.5 million discharges were due to major
cardiovascular events with 400,000 reported as ischemic heart disease, and 251,000 reported as
stroke (CDC, 2017). Moreover, in 2014, 52,159 people developed end-stage renal disease with
diabetes as the primary cause (CDC, 2017). Diabetes not only affects patients physically, but
also economically affects individuals and taxpayers as whole. In 2017, the total cost of diabetes
in the United States (US) was estimated to be $327 billion, with $237 billion related to direct
medical costs, and $90 billion related to reduce productivity (American Diabetes Association
(ADA), 2018). Average medical expenditures among people with diabetes is 2.3 times higher
than people without diabetes (ADA, 2018). Furthermore, according to CDC (2017), 84.1 million
people age 18 years and older, or 33.9% of US population have prediabetes.
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Prediabetes is a condition whereby blood sugar levels are higher than normal but are less
than the values required to diagnose diabetes. According to ADA (2018), normal Glycosylated
hemoglobin A1c (HbA1c) is less than 5.7%, and for prediabetes an acceptable A1C is between
5.7% and 6.4%. For a patient to be diagnosed with diabetes, their A1C must be 6.5% or greater.
Having prediabetes increasingly puts an individual at risk for developing type II diabetes,
especially in the presence of strong family history, lack of physical activity, and poor diet.
Adoption of meaningful life style modifications such as losing weight, moderate intensity
physical activity and healthy diet, can reduce the risk of prediabetes progressing to full diabetes
by as much as 58 % (CDC, 2017).
In my previous practice, approximately 90% of my patients have one or two diagnoses of
mental illness. Thus, an additional diagnosis of diabetes becomes very challenging for both the
patient and the provider because certain antipsychotic drugs can exacerbate blood sugars. These
patients also because of their multiple co-morbidities have difficulties following through with
their follow up appointments and recommended life style modification. Approximately 15% of
my patients at the time have type II diabetes. The average HbA1c in the clinic was 7.4%, and
approximately 20% of the patients who have diabetes are either overweight or obese. The
average body mass index (BMI) at the clinic was 36, while normal BMI is below 25kg/m^2.
There is a clear need for better management of diabetes within this patient population.
Patient education and their involvement in care is an important part of the overall management of
diabetes to prevent complications. One of the emerging and innovative ways to accomplish this
is through shared medical appointment (SMA), also known as group visits. During SMA visit, a
medical provider attends to each patient for 3-10 minutes in a group setting, eliciting
conversation and discussion of patient’s medical problems with the group for a longer period so

2

that assessment becomes part of the education, and patient to patient interaction becomes a
learning opportunity. A discussion among patients elicits positive health behavior change
including: medication management, education about diabetes, self-management strategies
including diet, exercise, and losing weight (Heyworth et al., 2014). Constructive patient
interactions are encouraged during SMA sessions. Interactions such as patients sharing success
stories with each other to motivate others who are not doing well in their management are
encouraged. Efficient and effective peer support is central to group sessions (Edelman at al.,
2014). SMA creates a supportive group environment where ideas and solutions are shared by
patients. The use of group as a treatment modality is rooted from social learning theory that
states that people learn new information from one another by watching other people and
imitating the behavior of others (Caballero, 2015).
In contrast, individual medical appointment (IMA) is when a patient sees a provider alone
in an exam room and the assessment and education takes place at that time in a typically short
visit. There is usually no patient to patient interaction and discussion of experiences (Watts et al.,
2015). The question now is which of these encounter modalities works best for patients with
diabetes.
PICOT Question
Therefore, the clinical question that arises is “In diabetic patients(P), how does shared
medical appointments(I) compared with individual medical appointments(C) affect hemoglobin
A1c results and BMI(O) in 3 months(T)?”
Systematic Search
To answer the PICOT question, a systematic search was conducted within the following
databases: Cumulative Index Nursing and Allied Health Literature (CINAHL), PubMed, and
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Cochrane database for systematic reviews (CDSR). The keywords from the PICOT question
were identified as “shared medical appointment,” “diabetes,” “hemoglobin A1c,” “individual
appointments” “mental health” and “body mass index”. Additionally, “Group visits” and “usual
care” were keywords identified during the searches. The search to find answers to clinical
question began with CINAHL. The individual keywords were searched initially, and the results
were saved in search history. Then different combinations of the keywords searched, yielding 19
citations. PubMed was searched with the same keywords and search strategy. Individual
keywords were searched initially and added to search history. Different hits obtained with this
strategy, then different keyword combinations were used, yielding 11 final citations. Lastly,
Cochrane Database for Systematic reviews (CDSR) was searched with the same keywords and
search strategy. Keyword combinations were used as in CINAHL and PubMed, first “group
visits” with “hemoglobin A1C” and the yield was 6 citations. Then “shared medical
appointments” and “diabetes” were searched, which yielded 12 citations.
The combined search results from the 3 data bases were reviewed for title. During this
process, out of the 42 total articles that were reviewed, 22 articles were excluded because either
the tittle was not relevant to the topic or SMA intervention was not done in diabetes. A total of
20 articles were selected for abstract review, and 3 additional articles were excluded after the
review because of duplication. A total of 17 studies were selected for full review. Two of the 17
studies were only study protocols without the results and were therefore excluded. This left a
total of 15 studies for critical appraisal (See appendix A, figure 1.0)
Selection of Evidence Based Practice (EBP) Model
The EBP model that guided the intervention was the Model for Evidence Based Practice
Change. This model is a revised version of the model by Rosswurm and Larrabee (1999). The
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revised steps and the schematic diagram were prompted by Larrabee’s experience with educating
and guiding nurses in the application of the original model since 1999 at West Virginia
University Hospitals (See appendix F, figure 1.1) (Dang et al., 2015).
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Chapter 2
Critical Appraisal of Evidence, Model of EBP & EPIP Plan: Part 1(EBP Process Steps 1,
2, 3, & 4)
Body of the Evidence
To find answers to the proposed clinical question, 15 quantitative studies were identified
and reviewed using rapid critical appraisal. The studies used various methodologies. After the
general appraisal overview (GAO) and rapid critical analysis (RCA), it was determined that all
the 15 studies reviewed will be relevant to the evidence synthesis. After identifying the keeper
studies, the information from GAO forms and RCA checklists was transferred to an evaluation
table to make appraisal easier across the studies (See appendix B, table A).
Hierarchy of evidence provides guidance during evidence review to determine which
evidence is likely to provide the most reliable answers to the clinical question. Out of the 15
studies reviewed, two were level I evidence, five were level II evidence, six were level III
evidence, one was level IV evidence, none were level VI evidence, and one was level VII
evidence (See appendix C, table B). Level I evidence is comprised of systematic review of
randomized control trials, and they are the strongest evidence (Melnyk, Morrison-Beedy, &
Cole, 2015).
Two out of the 15 studies reviewed were level I evidence. Edelman et al. (2014) and
Housden et al. (2013) conducted systematic reviews to evaluate the effectiveness of the SMA in
reducing HbA1c levels in patients with poor blood sugar control. Both studies included in their
review randomized control trial (RCT) and observational studies. The studies included in
Edelman et al. (2014) study were 13 RCT and four observational studies, with a total of 17
studies reviewed (See appendix B, table A). Housden et al. (2013) included 26 studies in their

6

review, out of which 13 studies were RCT (Appendix B, table A). Out of the 13 RCTs which
both studies reviewed, 10 were duplicates and the other three studies were different. One study
utilized meta-analysis, while the other study was systematic review only. Both studies measured
hemoglobin A1c as an outcome, and the results improved in both studies among those who
attended SMA. Edelman et al. (2014) also measured lipid values and blood pressure, which all
improved from baseline (See Appendix C, Table C). Both studies concluded that SMA was
effective in reducing hemoglobin A1c levels. Moreover, Edelman et al. (2014) additionally
concluded that SMA was effective in reducing lipid values and blood pressure as well.
Therefore, since level I evidence is considered the highest level of evidence in evidence
hierarchy, and based on the conclusion of the two studies, SMA should be recommend as the
standard of care in managing diabetic patients to improve outcomes.
Randomized control trials are considered level II evidence and are the strongest design to
test for cause and effect. They usually provide reliable evidence that can be used to make
decisions regarding EBP (Melynk, Morrison-Beedy, & Cole, 2015). Out of the five RCTs
reviewed, one conducted SMA every month, two studies monthly, and two studies four times
weekly followed by five monthly SMA booster sessions. The duration of the studies varied, two
studies conducted SMA lasting 1.5 hours per session, two lasted for two hours per session and
one did not mention the duration of the SMA per session. The total duration of the SMA was as
follows: one lasted for 12 months, two lasted for six months, one lasted for three months and one
lasted for 15 months (See Appendix C, Table D). The curriculum of the SMA education was
very similar across the studies. Four out of the five RCTs reviewed included medication
management, all the five studies included nutrition, three included exercises, three included
behavior counseling, four included diabetes overviews, and three included foot care (See
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Appendix C, Table E). For SMA logistics, five out of five studies included medical management,
group support, Diabetes Self-Management Education (DSME), a nurse, and a medical provider.
Two studies included 4-6 patients per group session, one study included 6-8 patients per group
sessions, and one study included 20-25 patients. Out of five studies, two included dietician, one
included exercise trainer, and one included counselor (See Appendix C, table F). For the
outcome measures across the studies, four out of the five studies measured hemoglobin A1c and
the values decreased compared to baseline. Three studies measured lipid values and all of them
indicated improved values. Five studies measured blood pressure and all five reported decrease
in blood pressure. One study measured weight, and reported decrease compared to baseline value
(See appendix C, table C). The studies concluded that SMA was effective in improving
hemoglobin A1c values, blood pressure, lipid values, and weight. These findings agree with
higher level 1 studies. Therefore, SMA should be recommend as the standard of care to improve
diabetes outcomes
Quasi-experimental designs are considered as Level III evidence and are experimental
studies without randomization to the intervention and control groups. This kind of design is
commonly used when randomization is not feasible. These designs are weaker than RCT (O’
Mathuna & Fineout-Overholt, 2015). Out of the six level III studies that were reviewed, five
measured hemoglobin A1c, three measured lipid values, three measured blood pressure, three
measured weight, and one measured knowledge as the outcomes of the intervention. Out of all
the five studies that measured hemoglobin A1c as the outcome of the intervention, the results
improved in each one of them compared to baseline values. The three out of the six studies that
measured lipid values, the results improved in two studies, and values reduced in one study, but
it was not statistically significant. The three out of the six studies that measured blood pressure
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reported improvement in the numbers. Out of the six studies, three that measured weight reported
a reduction, but one study reported none statistically significant reduction. Lastly, one study
measured knowledge, and the results indicated increased in the outcome (See appendix C, table
C). Out of the six studies reviewed, one conducted SMA monthly, two weekly, one biweekly,
and one weekly four times, then two bi monthly booster SMA sessions. Out of the six studies,
two studies lasted for two hours per SMA session, two lasted for three hours, and one lasted for
1.5 hours. For the total duration of the studies, one lasted for a total of three months, one lasted
for three weeks, one lasted for four weeks, one lasted for eight weeks, and one lasted for five
months (See appendix C, table D). For the SMA education curriculum, four out of the six studies
included medication management, four included nutrition, four included exercise, four included
behavioral modification teaching, four included diabetes foot care, and two included diabetes
overview education (See appendix C, table E). For SMA logistics across the studies, six out of
six studies reviewed incorporated medical management in the SMA, six out six included peer
support, six out six included DSME, one study utilized 4-20 patients per group session, 1 utilized
11 patients per group, and 1 utilized 4-6 patients per group, six out of six studies included a
medical provider, three out six studies included a nurse, two included a dietician, and 1 included
a counselor (See appendix C, table F). The studies concluded that SMA was effective in
improving hemoglobin A1C values, blood pressure, lipid values and increased patient
knowledge. This conclusion agrees with the findings of higher level 1 and II studies. Therefore,
SMA should be recommended as the standard of the care in managing diabetes patients.
Cohort designs are considered level IV evidence. In this study design, the researchers
follow a group of people who are exposed to a condition to see if they will develop an outcome
of interest. The researchers follow patients for a long time, and as a result the study is usually
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considered as a longitudinal study (Melnyk, Morrions-Beedy, & Cole, 2015). This was the only
cohort study out of the 15 studies reviewed. The study measured hemoglobin A1c as the only
outcome and the results improved (See appendix C, table C). The SMA duration per session was
1.5 hours and the total duration of the intervention lasted for 12 months (See appendix C, table
D). The study included in the SMA education plan includes medication management, nutrition,
exercise, behavior modification, and diabetes overview (See appendix C, table E). The study
logistics included medical management of patients during the visit, peer support, DSME, the
study utilized 8-15 patients per session, the study included a nurse, a medical provider, and a
health psychologist (See appendix C, table F). The study concluded that SMA was effective in
improving hemoglobin A1c values. This level IV study findings agrees with higher level 1, II,
and III studies. Therefore, SMA should be recommended as the standard of care in managing
diabetes patients.
Finally, Ridge (2012) conducted a literature review regarding SMA. The review included
different research designs, including randomized control trials and non- randomized control
trials. Literature reviews are considered as lower tier evidence, and therefore, their findings
cannot be solely used to base practice change. However, the results of this review concluded that
SMA can be effective in improving hemoglobin A1c, knowledge, and quality of life in patients
with diabetes, which agrees with higher tier levels of evidence. (See appendix B, table A).
Based on the evidence from the studies, diabetes self-management skill education must
be included in any SMA intervention. This topic was common across all the studies reviewed
(See appendix C, table E). This is an important component of the SMA intervention. Studies
have found that patients are likely to participate in their own care if they have a better
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understanding of their disease process and self- care measures (Caballero, 2015). Therefore,
diabetes self-management should be integrated in all SMA interventions.
After an exhaustive and systematic search of the literature to help gather evidence to
answer the clinical question, an evaluation table was created from which a synthesis table was
also created outlining the current state of the evidence regarding SMA. Creation of the synthesis
table helped bring clarity to the current state of the evidence and its practice worth. After a
thorough review of the synthesis table, it is now very clear that SMA is effective in reducing
hemoglobin A1c and helps patients meet their hemoglobin A1c goal of less than 7. Out of the 15
quantitative studies that were reviewed, 13 measured hemoglobin A1c as the primary outcome of
the intervention, and all 13 studies found that SMA was effective in reducing A1c (See appendix
C, table C). The conclusions from several studies comparing IMA to SMA supported that SMA
is more effective.
Recommendation from Evidence Synthesis
SMA should be recommend as the standard of care for diabetes management, and each
SMA session should include: DSME, medical management, and peer support as recommended in
the body of the evidence.
Ethics and EBP
The ethics of EBP implementation involves planning a protocol that is in conformity with
all the ethical standards. During the project protocol planning, all the ethical standards were
observed, and all the interventions planned in way that contributed to the improvement of patient
care and not put patients at risk. Unlike research methods, there is no inclusion or exclusion
criteria for EBP implementation. It is unethical to include some patients in receiving best
practice while excluding others. Best practices should be offered to all patients and it is up to the
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patients to either participate or refused. If patients refused, they should not be coerced or forced
to participate thereby violating their autonomy. SMA intervention was offered to all the diabetic
patients in the clinic. The planning of the project involved designing of a logic model (See
appendix H, figure 1.3). This planning included outlining the activities of the project such as
process makers.
Clinicians should always provide care to their patients using evidence that has been
vigorously vetted. Using evidence in clinical practice that is unvetted, is not only unethical, but it
will not produce desired results. EBP implementation projects are based on research studies that
have been already completed and risks associated with the intervention already known. Because
of this, patients are not exposed to new risks and informed consent is not usually required. This,
however, does not mean that patients will not be exposed to any risks. Data collection from
patients for evaluation of the intervention effectiveness can put patients at risk for privacy
violation. (O’Mathunna, 2011). The practitioner must make sure that patient data that are
collected are safeguarded to prevent violations of patient right to privacy. Some of the ways this
can be accomplished is by putting the data in a password protected computer or also
deidentifying patient names. All patient information that was collected was safeguarded and
protected by deidentifying patient names and putting the data in a password protected computer.
Patients were also protected from any harm that could be cause by the implementation.
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Chapter 3
Project Design and Methodology (EBP Process Steps 3-4)
Project Design and Methodology Overview
Staff education was completed on 1/19/18, this was followed by Institutional Review
Board (IRB) review of the project to determine if it meets the requirement for IRB oversight.
This process was initiated in January 2018 and was completed on March 8th, 2018 with
exemption and approval of the project to move forward by IRB. SMA sessions started on 3/23/18
and continued weekly four times, then two biweekly booster SMA sessions. Data analysis
followed the booster SMA sessions, and this lasted through June 2018. Finally, dissemination of
the project results began in January 2019 through July 2019, and sustainability plan will also
continue through July 2019 (See Gantt chart in appendix L, table L)
Resources Required for Project/Cost
Resources are a critical part of the success of any project. The following resources were
noted as critical to the SMA implementation: Office space, staff, computer with internet
connection, furniture, device for indirect non-invasive mean arterial pressure (dinamap),
electronic scale, educational materials such as flyers, booklets and posters, stethoscope, budget,
HbA1c machine, monofilament, microalbumin machine, microalbumin strip, other medical
equipment such as ophthalmoscope and otoscope office supplies such as printers, papers, stapler,
and scanners. Staff payroll was also central to the success of the project. It was estimated that 22
total SMA hours would be required to implement the project. Nurse practitioner, Registered
Nurse and Certified Medical Assistant hourly pay was calculated and added to the total budget of
the project. The total amount including staff pay roll and resources cost was $22,268.93 (See
appendix K, table K).
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Fully Operationalized Project (Month by month-Week by week Project Plan)
On November 2017, the University of Texas Southwestern medical center (UTSW)
Advance Practice Department IRB application form was reviewed and completed.
On December 2017, a conditional approval letter from Advance Practice Department at
UTSW to move forward with the project pending IRB review for exemption was received.
Project protocol was finalized during this month as well. All the diabetic patients were notified
regarding the upcoming SMA implementation in the clinic. All the stakeholders and industry
mentor were notified about the date of the implementation.
January 19th, 2018/Week 0 pre-implementation- On January 19th, the implementation
team met to receive in-service training on the project protocol. We discussed the logistics of the
project. All the resources were reviewed, including the room where the intervention took place.
The clinic manager was not able to attend this meeting, but she was briefed on the project
implementation on a different date. The process outcome of staff education on project protocol
was completed on this day by the medical provider in the clinic. The entire project protocol was
discussed using demonstration technique. We went through the project protocol week by week to
rehearsed what is going to happen on each day of the implementation. We confirmed that
patients have been informed about the upcoming SMA, and a choice was given to them to
schedule appointments.
March 23rd, 2018/Week 1 implementation- First week of implementation, baseline data
was collected on this day. The following occurred during the first week of implementation:
•

Patient registration by the clinic medical assistant was carried out at the
receptionist desk using EPIC EMR once patients walked into the clinic. Patients
were escorted to the group room where vital signs, including weight were
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collected by the clinic Registered Nurse (RN) and documented in the EPIC
Electronic Medical Records (EMR) for each patient. Baseline data which
included: HbA1c, BMI, blood pressure (BP), and lipid values, were queried from
EPIC and values were transferred to Excel sheet by the nurse practitioner (NP).
These values served as the baseline data. Diabetes knowledge test was also
administered by the NP using University of Michigan Diabetes Research and
Training Center Diabetes Knowledge Test in the group room. The scores of this
initial test served as the baseline data.
•

NP reviewed patient charts in provider office by going through each participant’s
chart while patients were being registered and vital signs taken.

•

Once all the patients were registered and seated in the group room, the
appointment started with icebreaker session and introduction. The staff introduced
themselves, and the NP asked each patient to introduce themselves to the group.
Patients were also reminded of the Health Insurance Portability and
Accountability Act (HIPPA) confidentiality rules by NP not to discuss any patient
information outside of the meeting (See appendix E, table H).

•

NP sequentially attends to each patient in the group starting with brief medical
history first, followed by brief physical examination and finally, discussion of the
laboratory results including hemoglobin A1c and medication management with
the participation of the group as peer support. Patients progress were discussed
verbally in the group. Once every patient was seen, this marked the end of the
appointment component of the visit. This segment lasted for about 5-10 minutes
per patient
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•

After each patient’s open appointment in the group, the facilitators (RN and NP)
conducted patient education with focus on diabetes self-management strategies,
using various methods including, pictures, handouts, cards and blackboard. The
curriculum included: diabetes overview (basics) including pathophysiology,
acceptable laboratory values for A1c, hypoglycemia, glucose monitoring and
complications; medication management, nutrition management, exercise, foot
care and behavioral modification (See appendix C, Table E) Week 1 education
was focused on diabetes overview: pathophysiology, and acceptable values for
HbA1c. This education was conducted by NP in the group room using American
Diabetes Association (ADA) professional resource handouts on HbA1c and
diabetes pathophysiology. The mode of delivery was
discussion/demonstration/handouts. Some of the following questions were
addressed during educational sessions: What is diabetes? What causes it? What is
HbA1c? what are acceptable values? When is HbA1c measured? How is HbA1c
different from serum blood glucose? And setting goals and making action plan.
These are some of the questions and topics that was addressed in the educational
session. This session lasted for 60 minutes (See appendix E, table H).

•

After the presentation, the floor was open for open discussion among patients
with the provider as the facilitator. Patents asked questions, and they were also
encouraged to share their success stories with their peers in the group. Patients
who met their glycemic goals were praised and were encouraged to lead the
discussion and educate those who were struggling with meeting their glycemic
targets. This session lasted for 30 minutes.
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•

The session ended with each patient setting a clear achievable goal as to how they
plan to improve their diabetes management before next meeting by writing the
goal down on a paper. The session was adjourned until next week.

March 29th, 2018/Week 2•

Patient registration by the clinic medical assistant was carried out at the
receptionist desk using EPIC EMR once patients walked into the clinic. Once that
was completed, patients were escorted to the group room where vital signs,
including weight were collected by the clinic RN and documented in the EPIC
EMR for each patient.

•

NP reviewed patient charts in the provider office by going through each
participant’s chart while patients were being registered and their vital signs taken.

•

Once all the patients were registered and seated in the group room, the
appointment started with introduction. Staff introduced themselves, and the NP
asked each patient to introduce themselves to the group. Patients were reminded
of the HIPPA confidentiality rules by the NP (See appendix E, table H).

•

NP then sequentially attended to each patient in the group starting with brief
medical history first, followed by brief physical examination and finally,
discussion of the laboratory results including hemoglobin A1c and medication
management with the participation of the group as peer support. While the NP
was attending to each patient, the peers supported the patient by sharing similar
stories. Patient’s progress was discussed verbally in the group. Once every patient
was seen, this marked the end of the appointment component of the visit. This
lasted for about 5-10 minutes per patient
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•

After each patient’s open appointment in the group, the facilitators (RN and NP)
conducted patient education with focus on diabetes self-management strategies,
using various methods including pictures, and handouts. Week 2 education was
focused on diabetes overview. The discussion included hypoglycemia and glucose
monitoring. The education was conducted by the NP in the group room using
ADA professional resource handouts on hypoglycemia and glucose monitoring.
Some of the following questions were addressed during educational sessions:
defining what is hypoglycemia? What can you do to avoid it? What are the signs
and symptoms of hypoglycemia? What are the complications of hypoglycemia?
What types of food can you eat to avoid hypoglycemia? The mode of delivery
was discussion/demonstration/handout. Setting goals and making action plans was
completed by each patient at the end of the SMA session. The session lasted for
60 minutes.

•

After the presentation, the floor was opened for discussion among patients with
NP as the facilitator. Patients asked questions, and they were also encouraged to
share their success stories with their peers in the group. Patients who are doing
well with meeting their glycemic goal were praised and were encouraged to lead
the discussion and educate those who did not meet their glycemic targets. This
session lasted for 30 minutes.

•

The session ended with each patient setting a clear achievable goal as to how they
plan to improve their diabetes management before the next meeting by writing
their goals down on a paper. The session was adjourned until the next meeting.
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April 6th, 2018/Week 3
•

Patient registration by the clinic medical assistant was carried out at the
receptionist desk using EPIC EMR once patients walked into the clinic. Once that
was completed, patients were escorted to the group room where Vital signs,
including weight was collected by the clinic RN and documented in the EPIC
EMR for each patient.

•

NP reviewed patient charts in the provider office by going through each
participant’s chart while patients were being registered and their vital signs taken.

•

Once all the patients were registered and seated in the group room, the
appointment started with introduction. The staff introduced themselves, and the
NP asked each patient to introduce themselves to the group. Patients were also
reminded of the HIPPA confidentiality rules by the NP.

•

NP then sequentially attended to each patient in the group starting with brief
medical history first, followed by brief physical examination and finally,
discussion of the lab results including hemoglobin A1c, and medication
management with the participation of the group as peer support. While the NP
was attending to each patient, peers shared their experience with similar situation.
Patient’s progress was discussed verbally in the group. Once every patient was
seen, this marked the end of the appointment component of the visit. This lasted
for about 5-10 minutes per patient

•

After each patient’s open appointment in the group, the facilitators (RN and NP)
conducted patient education with focus on diabetes self-management strategies,
using various methods including, pictures, and handouts. Week 3 education was
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focused on diabetes complications and medication management. This education
was conducted by the NP in the group room using ADA professional resource
handouts on hypoglycemia and glucose monitoring. We discussed oral diabetes
medications and the importance of adherence. We discussed which medications
are insulin sensitizers, and those that can cause hypoglycemia. We also discussed
insulin including self-titration using sliding scale, appropriate injection sites, and
potential for hypoglycemia. We discussed diabetes complications which included
macrovascular complications (coronary artery disease, stroke, and peripheral
artery disease) and microvascular complications (retinopathy, nephropathy and
neuropathy). The mode of delivery was discussion/demonstration/handout.
Setting goals and making action plans was completed by each patient at the end of
the SMA session. This session lasted for 60 minutes.
•

After the presentation, the floor was opened for discussion among patients with
the NP as the facilitator. Patents asked questions, and they were also encouraged
to share their success stories with their peers in the group. Patients who did well
with meeting their glycemic goals were praised and were encouraged to lead the
discussion and educate those who did not meet their glycemic targets. This
session lasted for 30 minutes.

•

The session ended with each patient setting a clear achievable goal as to how they
plan to improve their diabetes management before the next meeting by writing
their goals down on a paper. The session was adjourned until the next meeting.

April 13th, 2018/Week 4
•

Patient registration by the clinic medical assistant was carried out at the
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receptionist desk using EPIC EMR once patients walk into the clinic. Vital signs,
including weight were collected by the clinic RN and documented in the EPIC
EMR for each patient.
•

NP reviewed patient charts in the provider office by going through each
participant’s chart while patients were being registered and their vital signs taken

•

Once all the patients were registered and seated in the group room, the
appointment started with introduction. Patients were also reminded of the HIPPA
confidentiality rules by the NP

•

The NP then sequentially attended to each patient in the group starting with brief
medical history first, followed by brief physical examination and finally,
discussion of the lab results including hemoglobin A1c and medication
management with the participation of the group as peer support. While the NP
was attending to each patient, peers shared their experience with similar situation.
Patient’s progress was discussed verbally in the group. Once every patient was
seen, this marked the end of the appointment component of the visit. This lasted
for about 5-10 minutes per patient

•

After each patient’s open appointment in the group, the facilitators (RN and NP)
conducted patient education with focus on diabetes self-management strategies,
using various methods including pictures and handouts. Week 4 education was
focused on nutrition management and exercise. (See appendix C, table E). This
education was conducted by the NP in the group room using ADA professional
resource handouts on nutrition management and exercise. We discussed about
carbohydrate counting, nutrition labels, “my food plate”, eating out, meal
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planning, heart healthy eating, food substitution, low fat diet, and DASH diet. We
also talked about types of exercise, barriers to exercises, adopting an exercise
regimen, and exercise and blood sugar. The mode of delivery was
discussion/demonstration/handout. This session lasted for 60 minutes.
•

After the presentation, the floor was opened for discussion among patients with
the NP as the facilitator. Patients who are doing well with meeting their glycemic
goals were praised and were encouraged to lead the discussion and educate those
who are struggling with meeting their glycemic targets. This session lasted for
30 minutes.

•

The session ended with each patient setting a clear achievable goal as to how they
plan to improve their diabetes management before next meeting by writing the
goals down on a paper. The session was adjourned until next 4 weeks

April 20th/Week 5•

No SMA was conducted this week. Patients worked on their goals.

•

Individual medical appointments continued in the clinic this week.

•

NP reviewed process outcomes to make sure everything is on target.

•

NP prepared for the SMA booster session and reviewed the education materials
for that session.

April 27th, 2018/Week 6 SMA booster session
•

Project milestone was reviewed on 4/30/18 by the NP

•

Evaluation of number of patients still attending the SMA sessions was reviewed
by NP.

•

Patient registration by the clinic medical assistant was carried out at the
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receptionist desk using EPIC EMR. Once was completed, patients were escorted
to the group room where vital signs, including weight were collected by the clinic
RN and documented in the EPIC EMR for each patient.
•

NP reviewed patient charts in the provider office by going through each
participant chart, while patients were being registered and their vital signs taken

•

Once all the patients were registered and seated in the group room, the
appointment started with introduction. Patients were reminded of the HIPPA
confidentiality rules by the NP.

•

The NP then sequentially attended to each patient in the group starting with brief
medical history first, followed by brief physical examination and finally,
discussion of the lab results including hemoglobin A1c and medication
management with the participation of the group as peer support. While the NP
was attending to each patient, peers shared similar stories. Patients progress were
discussed verbally in the group. Once every patient was seen, this marked the end
of the appointment component of the visit. This lasted for about 5-10 minutes per
patient

•

After each patient’s open appointment in the group, the facilitators (RN and NP)
conducted patient education with focus on diabetes self-management strategies,
using various methods including pictures and handouts. Week 6 education was
focused on foot care. (See appendix C, table E) This education was conducted by
the clinic RN in the group room using ADA professional resource handouts on
diabetic foot care. Proper foot care for diabetics, diabetes foot ulcers, and when to
visit podiatrist was discussed. The mode of delivery was
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discussion/demonstration/handout. Setting goals and making action plan was
completed by each patient at the end of the SMA session. This session lasted for
60 minutes.
•

After the presentation, the floor was opened for discussion among patients with
the NP as the facilitator. Patents asked questions, and they were encouraged to
share their success stories with their peers in the group. Patients who are doing
well with meeting their glycemic goal were praised and were encouraged to lead
the discussion and educate those who are struggling with meeting their glycemic
targets. This session lasted for 30 minutes.

•

The session ended with each patient setting a clear achievable goal as to how they
plan to improve their diabetes management before next meeting by writing their
goals down on a paper. The session was adjourned until next 4 weeks

May 4th/Week 7•

No SMA conducted in the clinic this week, patients worked on their individual
goals.

•

NP was available to answer any patient questions in the clinic.

•

Individual medical appointments continued in the clinic.

May 11th, 2018/ Week 8
•

Patient registration by the clinic medical assistant was carried out at the
receptionist desk using EPIC EMR once patients walked into the clinic. Once that
was completed, patients were escorted to the group room where vital signs were
collected by the clinic RN and documented in the EPIC EMR for each patient.
Weights were obtained, and BMI re-calculated again. Hemoglobin A1C was also
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obtained on this day to compare the data to baseline information. Quarterly lipid
values were ordered for patients who do not have a recent value in EPIC as
completion outcome data. Blood pressure was obtained on this day to serve as
completion outcome data. All these data were transferred to an Excel sheet for
data analysis.
•

NP reviewed patient charts in the provider office by going through each
participant’s chart, while patients were being registered and their vital signs taken

•

Once all the patients were registered and seated in the group room, the
appointment started with introduction. Patients were also reminded of the HIPPA
confidentiality rules by the NP

•

The NP then sequentially attended to each patient in the group starting with brief
medical history first, followed by brief physical examination and finally,
discussion of the lab results including hemoglobin A1c and medication
management with the participation of the group as peer support. While the NP is
attending to each patient, the peers shared similar experiences. Patients progress
were discussed verbally in the group. Once every patient was seen, this marked
the end of the appointment component of the visit. This lasted for about 5-10
minutes per patient

•

After each patient’s open appointment in the group, the facilitators (RN and NP)
conducted patient education with focus on diabetes self-management strategies,
using various methods including pictures and handouts. Week 8 education
focused on behavioral modification (See appendix C, table E) This education was
conducted by the NP in the group room using motivational interviewing
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techniques. Topics included readiness to change. The mode of delivery was
discussion/demonstration/handout. This session lasted for 60 minutes.
•

After the presentation, the floor was opened for discussion among patients with
the NP as the facilitator. Patients asked questions, and they were also encouraged
to share their success stories with their peers in the group. Patients who were
doing well with meeting their glycemic goal were praised and were encouraged to
lead the discussion and educate those who were struggling with meeting their
glycemic targets. This session will last for 30 minutes.

•

The SMA session ended on this day with re-administration of knowledge test that
was administered on the first day of the implementation using University of
Michigan Diabetes Research Training Center Diabetes Knowledge Test. The
results were compiled and enter Excel sheet for analysis.

•

This session concluded the SMA sessions. All the patients were thanked for their
attendance.

Process Indicators with Lessons Learned, Barriers and Solutions
There were several measures that were obtained during and after the intervention. The
process outcome measures included: project protocol training, staff education, and data
collection. These are processes that were required to achieve the project impact outcomes. Staff
training, and education was measured by the rate of completion. The completion outcomes of
SMA such as hemoglobin A1c, blood pressure, lipid values, knowledge, and BMI were
measured at the end of the intervention (See Appendix I, table I) Other important outcomes such
as financial impacts were measured as well as cost savings. The baseline HbA1c, blood pressure,
lipid values, knowledge, and BMI were obtained from each participant before the intervention,
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and these values were obtained after the intervention again. The financial impacts were measured
in terms of A1c reductions and prevention of potential complications.
Model for Evidence-Based Practice Change/EBP Process
Step 1 of The Model for Evidence-Based Practice Change (MEBPC) (See Appendix F,
figure 1.1) was to assess the need for change in practice. In following the EBP process, the first
step was to identify a clinical issue. Current national guidelines on diabetes recommend HbA1c
goal of below 7% for adults in general and below 8% for the geriatric population. In my previous
clinic, average hemoglobin A1c was 7.4%. National guidelines define normal BMI as less than
25kg/m^2 and obese as BMI greater than 30kg/m^2; my previous clinic average BMI is
36kg/m^2. In comparing the internal and external data, it is evident that improvement is needed
to meet the national standards for hemoglobin A1c and BMI. The clinical issue in my former
clinic was that some of the diabetic patients were not meeting the recommended hemoglobin A1c
goal of less than 7%. A clinical question was then formulated to help locate the best evidence
from the literature.
Step 2 of the MEBPC model was to locate the best evidence with the clinical question as
a guide. This is step 2 of the EBP process. Using systematic search strategy, a literature search
was conducted. Using intervention, comparison, and outcome keywords from the PICOT
question, CINAHL, PubMed, and Cochrane databases were systematically searched. The
searches yielded articles with the following levels of evidence: two level I evidence, five level II
evidence, six level III evidence, one level IV evidence, none level VI evidence, and one level VII
evidence.
Step 3 of the MEBPC model was to critically analyze the evidence. Step 3 of the EBP
process is critical appraisal. Critical appraisal began with rapid critical appraisal of each
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individual study, using GAO/RCA forms. Relevant information was transferred from the
GAO/RCA forms to an evaluation table, and then five synthesis tables were created on level of
evidence, outcomes, SMA duration and frequency, SMA education curriculum, and SMA
logistics. The outcome synthesis table verified that SMA has been shown to be effective in
reducing hemoglobin A1c across 13 of 15 studies. What stood out from the evidence synthesis
was that SMA duration and frequency in the group sessions ranged from 1.5-4 hours, with most
lasting 2 hours, how often SMA was conducted ranged from weekly to monthly, with most
conducted weekly, and the total duration of SMA ranged three weeks to four years, with most
lasted three months. For SMA education curriculum, DSME was common to all the studies.
Most of the studies included: medication management, nutrition, exercise, behavior modification,
diabetes overview and foot care. Most of the studies conducted SMA with small groups ranging
between 4-20, with most using 4-6 patients per session. All the SMAs included medical
management, DSME and peer support. The inter-professional team in the studies consisted of a
medical provider, a nurse, a dietician, an exercise counselor, and a health psychologist. Most of
the studies reviewed included just a medical provider and a nurse. The synthesis tables helped in
the decision-making process of appraisal for practice change based on the evidence, and the
recommendations.
Step 4 of the MEBPC model was to design practice change. This is step 4 of the EBP
process. Once the body of the evidence is critically appraised, evaluated, and synthesized, it
should be integrated with clinician expertise plus patient’s preferences and values to determine if
it should warrant practice change. I have already had preliminary meetings with the clinic
leadership including my industry mentor. During these meetings, we discussed what the evidence
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revealed about SMA and what my vision moving forward for the clinic was going to be in terms
of practice change
Step 5 of the MEBPC model is to implement and evaluate change in practice. This is
steps 5 & 6 of the EBP Process, in which application of the evidence to practice is evaluated. The
protocol that was designed in step 4 guided all the implementation. Since the strategies and
methods that were used in the studies was successful in reducing hemoglobin A1C, the same
strategies were replicated in the project. Based on the evidence, most of the studies used pre-and
post -test to compare the effectiveness of the intervention. Pre-data were collected from all the
patients at the beginning of the intervention, and post data collected after intervention. Baseline
data included: A1c, BMI, blood pressure, lipid values, were queried from EPIC and values
transferred to an Excel sheet by the NP. These values served as the baseline data. The project
enrolled a small group of 4-6 patients per group session, meet weekly four times and two
monthly sessions, and each session lasted for two hours per session as recommended from
evidence synthesis. The total duration of the intervention lasted for three months.
Step 6 of the MEBPC model is the integration and dissemination stage. The EBP process
stage for this are steps 5 and 6, which are evaluation and dissemination of the outcomes. The preintervention data was compared to the post intervention data to determine effectiveness. Based
on the data, SMA was determined to be effective. Since SMA was effective, NP should make
sure that the change is integrated and maintained into practice. NP should also promote
evidence-based practice in organizations. SMA should be incorporated into the standard of care
and clinical guidelines should reflect this change. The results of the project will be disseminated
through presentation and manuscript.
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The DNP role in upholding ethical standards is important. Since EBP interventions are
mostly conducted by the DNPs, they need to ensure that each step of the EBP process is
observed and abides by the ethical standards. DNP needs to further ensure that the EBP
implementation is in the best interest of the patient, and they also need to make sure that no harm
is done to patients during the implementation. All patients need to be treated equally during the
implementation as well. Lastly, DNP need to also make sure that patients’ autonomy and privacy
are safeguarded.
Theoretical Framework
Self-efficacy is a concept which is derived from social cognitive theory and refers to an
individual’s ability to perform his/her duties and responsibilities. This concept can be used to
describe the interaction between personal and behavioral factors in chronic illnesses and predicts
health behavior. Self-efficacy has been found to contribute to the self-management behaviors
among patients with various chronic illnesses (Lalnuntluangi, Chelli, & Padhy, 2017). Several
quantitative studies have explored the relationship between self-efficacy and self -management
of diabetes. Among the studies that explored this relationship, Venkataraman et al. (2012)
concluded that a strong positive association exists between self-efficacy and measured blood
sugar status. The study also found that self-efficacy is the strongest determinant of current blood
sugar status. Other studies including Lalnuntluangi et al. (2012), Greenberger et al. (2014), Gao
et al. (2013), and Alipour et al. (2012) all had similar conclusions that higher self-efficacy
translates into better self-management practices, better hemoglobin A1c, and better overall
management of diabetes. Self-efficacy concept is, therefore, an important concept in diabetes
management.

30

The health belief model (HBM) (See appendix G, figure 1.2) guided the SMA
intervention. Perceived susceptibility/seriousness (severity) of disease is a patient’s
understanding of the seriousness of the disease and susceptibility to the disease. Personal risk to
the disease is a motivating factor to prompt people to adopt a healthier life style. The greater the
risk is perceived, the higher the likelihood of behavior change to decrease the risk (Hayden,
2009). This concept represents uncontrolled diabetes in this project. Uncontrolled diabetes can
lead to complications of diabetes, which represents a threat to the patient (perceived threat of the
disease). Cues to action concept in the theory has a premise that people’s behavior can be
influenced by cues to action. Cues to action are events, people, or things that lead people to
change behavior. Examples are a family member having a heart attack, media reports, mass
media campaigns, advice and education from a healthcare provider, and warning labels from
products (Hayden, 2009). Through SMA, patients became aware of health threats from diabetes.
During SMA sessions, patients collaborated with the provider and their peers by sharing valuable
information regarding the management of diabetes. Peer support and disease knowledge
represent modifying factors such as sociopsychology and structural variables. These individual
characteristics such as peer support and knowledge of the disease can influence personal
perception. They also help patients to be aware of the complications of the disease and the
benefits of changing behavior (perceived - benefits of preventive action) (Hayden, 2009).
Perceived benefits of the preventive action versus perceived barriers to the preventive action
determines the likelihood of taking recommended preventive health action (Self -efficacy),
which lead to the outcome of the intervention: reduced hemoglobin A1c, BMI, and blood
pressure.

31

Logic Model
The logic model guided the EPIP project in that it laid out the project assumptions,
external influences, activities, inputs, outputs, and outcomes (See appendix H, figure1.3) The
SMA assumptions were that diabetes patients will chose SMA over IMA. The external influence
was that some patients might have difficulty with transportation, and they will not be able to
attend SMA regularly. Another factor was the funding status of the primary care outreach
program. Project input/resources were materials that were needed to conduct the project
successfully. The following resources were needed for the project: Office space, staff, computer
with internet connection, furniture, dinamap, electronic scale, educational materials such as
flyers, posters, stethoscope, budget, HbA1c machine, other medical equipment such as
ophthalmoscope and otoscope, office supplies such as printers, papers, and scanners. The
activities were the process makers that determined the success of the project and how it was
going. Meeting these processes makers timeline indicated that the project was going well.
Outputs in the logic model are the number of SMAs conducted per week. Lastly, the outcome is
divided into short, medium, and long term. The short-term goal is, patients recognize that
uncontrol diabetes can lead to serious complications, the medium-term goal is, more patients will
attend SMA visits, and the long-term goal is to achieve HbA1c < 7% each patient.
The planning of the project involved designing of a logic model. This planning included
outlining the activities of the project such as process makers. All process makers were ethical
and followed the decision triangle principles by making sure that the evidence and theory guides
the logic model and ethical principles guides the decisions making.
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Evaluation of EBP Model, Theoretical and Logic Model Function within EPIP
The EBP model that guided the implementation of the project was the model for
evidence-based practice change (See Appendix F, figure 1.1). Each of the steps of the model are
like the EBP steps, which helped create a more coherent synergy between the model and EBP
process. The health belief model (HBM) provided theoretical framework for the implementation
of the EPIP. This model, in addition to the EBP and logic model, provided a philosophical
guidance to the implementation. The logic model provided the inputs, output, and outcomes of
the EPIP. The various concepts of the HBM, logic model, provided synergy with the steps of the
EBP model, that helped provide motivation and self-efficacy, which helped some of the
participants to change behavior.
Quality Improvement Metrics for Sustainability
The sustainability plan includes designing a new policy for a system wide
implementation of SMA. The process of sustainability started on the day of implementation. This
process is an important step in the implementation and will take several months (See Appendix
L, table L). The new policy should be presented to the senior administrative officials for
consideration. If the new policy is approved, system wide training should be conducted to
prepare the staff for the system wide roll out of SMA. Once the SMA is implemented system
wide, the sustainability plans should include clinic-based mentors who will be recruited to assist
staff and answer any questions which they might have. These clinics-based mentors should be
knowledgeable in the project protocol and SMA in general. A conceptual model such as
advancing research and clinical practice through close collaboration (ARCC) should be used to
strengthen EBP in organization as a system and to help sustain SMA in all the clinics. Another
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strategy to sustain SMA is using the Plan-DO-Check-Act QI metric. This can help with ongoing
quality improvement to further improve and sustain SMA in the organization
Sustainability is a critical step in the EBP intervention process. The goal of EBP
intervention is to provide the best practice to the patients and have plans in place to make sure
that the best practice is sustained. It is unethical to embark on EBP intervention without any
suitability plan. If an EBP intervention cannot be sustained, the valuable resources that have been
invested in the intervention are wasted; this violates the ethical standard of justice.
Project Approvals
This project required three approval processes. One was required from the IRB office to
make sure that all the regulatory policies are followed. This was in the form of a review, it
required an initial two-page form consisting of yes or no questions to determine if the project
will require a full IRB review application process. Based on the answers on the form, the
reviewers determined that this project does not meet the requirement for IRB oversight. The
department of Advance Practice at UTSW also approved the project. Lastly, the project also
required the approval of University of Texas at Tyler.
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Chapter 4
Project Outcomes, Impact, and Results (EBP Process Step 5)
Completion Outcomes: Data collection, Data Analysis, Measurement, and Analysis of the
Project Results and Impact
Baseline data was collected from all patients on the first day of the intervention by the NP
after completing the registration process. The information that was collected included:
Hemoglobin A1c, blood pressure, lipid values, initial knowledge test, and weight to calculate
initial BMI. Data on these outcomes were queried from EPIC EMR using the report tab, then
selecting “my reports”, then choosing “my diabetes patient”, and then choosing “date range” and
“run” to obtain results.
The initial data was transferred to an Excel sheet. These values served as the baseline
data. A diabetes knowledge test was administered by the NP using The University of Michigan
Diabetes Research and Training Center Diabetes Knowledge Test in the group room. This was
completed once the HbA1c, BP, and Lipid values baseline data collections were finished. The
scores of this initial test served as the baseline data. Data was collected again post intervention as
it was done in the studies. The HbA1c was measured using the usual Siemens DCA Vantage
HbA1c Analyzer for those who did not have recent HbA1c in EPIC EMR. Blood pressure was
measured using Welch Allyn Dinamap; lipids were measured using the UTSW laboratory; an
electronic scale was used to capture the weights of each patient to enable BMI calculation; and,
knowledge was measured using University of Michigan Diabetes Research Training Center’s
(UMDRTC) Diabetes Knowledge Test. The results of post-intervention data were compared to
the baseline, and the aggregate mean reduction in the outcome values were noted and recorded.

35

The pilot intervention for SMA was implemented on March 23rd, 2018 through May 5th,
2018. A follow up encounter to collect missing data was conducted on May 25th, 2018. Six
patients participated in the intervention, but post-intervention data was collected on four patients.
The two patients that participated were not available for post intervention data collection. Premean intervention data for hemoglobin A1c, systolic blood pressure, diastolic blood pressure,
body mass index, lipid values, and knowledge was collected on the six participants and recorded.
Post mean values were collected for HbA1c, blood pressure, BMI, and knowledge (See appendix
M, figure 1.4) Lipid values were available for one of the four patients. Post-mean values were
calculated on four patients who attended two or more SMA sessions. Pre- and post-mean values
were calculated for participants who attended three or more SMAs (See appendix M, figure 1.5).
In July of 2018, a retrospective chart review of SMA was conducted at North Dallas
Shared Ministry (NDSM). Data was collected on 17 patients who participated in SMA from
January 2017 to June 2018. Out of the 17 patients, 13 were females and four were males. The
age range was from 32-66 years. Data was collected on outcome values of hemoglobin A1c,
blood pressure, lipid values and body mass index. Data analysis revealed that outcome values
improved, but were not statistically significant (See appendix M, table M). HbA1c improved
from a pre-mean of 8.0% to a post mean of 7.5% (p=0.139); systolic blood pressure decreased
from a pre-mean of 133 mmHg to a post=mean of 126 mmHg (p=0.145); diastolic blood
pressure decreased from 81 mmHg to 75 mmHg (p=0.043); total cholesterol improved from a
pre-mean of 190 mg/dl to a post-mean of 183 mg/dl (p=0.337); LDL improved from a pre-mean
of 99 mg/dl to a post-mean of 95 mg/dl (p=0.433); and, HDL improved from a pre-mean of 47
mg/dl to a post-mean of 48 mg/dl (p=0.470). Triglycerides, however, increased from a pre-mean
of 221mg/dl to a post-mean of 222 mg/dl (p=0.985); and, body max index improved from a pre-
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mean of 35 kg/m2 to a post-mean of 34 kg/m2 (p=0.139) ( See appendix M, figure 1.7). Another
key finding includes the percentage of patients reaching their HbA1c goals which increased from
25% to 38% post-intervention (See appendix M, figure 1.9). The number of patients at goal for
hypertension increased from 65% to 88% (See appendix M, figure 2.0).
Evidence from the literature was synthesized and presented in synthesis tables to better
visualized the effects of SMA on outcomes. Each of the studies in the synthesis tables in body of
evidence indicated that SMA was effective in reducing HbA1c, BP, BMI and lipid values levels.
SMA was also found to increase patient knowledge. Findings in the pilot SMA and the
retrospective chart review are consistent and comparable with the evidence. In the pilot SMA
implementation, the average values for HbA1c, BP, and BMI all decreased post-intervention
evaluation as suggested in the body of the evidence. The reductions in these values are more
pronounced for patients who attended greater than three or more SMA sessions. Knowledge
increased from 52% to 92% post intervention (See appendix M, figure 1.4). Lipid values were
not evaluated due to very limited data. For the retrospective chart review, findings suggest
reductions in the HbA1c, BP, BMI, and lipid values (See appendix M, figure 1.7).
Projected Project Costs/Savings
Based on the evidence, the implementation of SMA is effective in helping patients to
meet their hemoglobin A1C goals and effectively achieve disease management outcomes.
However, the budget is an important element of any project planning endeavor, as well. Without
financial resources the project cannot be brought to actualization. The cost of diabetes care in the
US is rising, and patients with diabetes complications incur more costs, placing severe burdens
on the entire healthcare system. Implementation of SMA, helping patients meet their glycemic
targets and avoiding complications that make diabetes care cost-prohibitive, result in substantial
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cost savings. Resources that will otherwise be used for diabetes complication care, can be
diverted to combat other chronic conditions. SMA has also demonstrated to improve the
productivity of medical providers and, thereby, increase revenue for the organization (Caballero,
2015). Considering the evidence gathered regarding SMA, an organization can design and
incorporate policies that will integrate SMA as the standard of the care, achieving optimal
outcomes and maximize use of resources.
The cost of diabetes care varies depending on the type of care and where the care is being
rendered. It is a well-established fact that when a diabetic patient seeks care in the Emergency
Department (ED), the cost of care is usually higher than that of a diabetic who seeks care in
his/her primary care provider’s office. The cost of care goes even higher if the person is admitted
to the hospital for a diabetes complication. For example, data from my former organization
revealed an average of $298 per visit if a diabetic seeks care in a primary care provider’s office.
The amount increased to an average of $2682 if the same care is rendered at the ED. The cost of
care further increased to $27,992 if the patient is admitted to the inpatient (hospital) setting with
diabetes complications (See appendix J, table J).
Considering the costs noted above, in addition to various diabetic care costs, a significant
amount of money can be saved if we can keep patients in the primary care arena. For example,
we can save up $2384 if the patient can avoid using the ER for diabetes care. We can also save
up to $27,693 per visit if we can prevent diabetes complications and prevent inpatient
hospitalizations. Based on five-day hospitalization care cost, we can expect a return in
investment savings of $1.993,968 per year if we can keep patients out of the hospital.
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Chapter 5
Project Sustainability Discussion, Conclusions, and Dissemination Recommendations
(Step 6)
Discussion of Project Results and Impact
The results of the pilot SMA were mixed. In comparing the pre-mean of the participants
to the post mean of the outcome values, HbA1c, blood pressure, and BMI dropped slightly, but
the post mean knowledge increased significantly (See appendix M, figure 1.4). In comparing the
pre and post mean of the HbA1c, the results indicate that those patients who consistently
attended SMA sessions and attended greater than three sessions have seen a significant drop in
their HbA1c values. For example, the patient with the project identification number 1003, had
consecutively attended all the first three SMAs plus an additional day, and his HbA1c dropped
from 10.2% to 6.9% (See appendix M, figure 1.6). This patient attended a total of four SMAs.
This indicates that the dose of SMA had an impact on this patient’s HbA1c level. In comparing
to the patients who attended at least two SMAs, but were not consistent with attendance, have
seen a slight increase in HbA1c level. Two out of three patients who also attended three or more
SMAs have seen a drop in their body mass index compared to pre-intervention values (See
appendix M, figure 1.6).
Although the results of the retrospective chart review outcome measures improved from
baseline, but the improvements were not statistically significant. This might be due to the small
sample size of the participants. Only the diastolic BP outcome was statistically significant
(P=0.043) (See appendix M, table M). The results of both the pilot SMA intervention and
retrospective chart review revealed that SMA outcomes improved including hemoglobin A1c
(See appendix M, figure 1.8). The reduction that was achieved in the interventions was predicted
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in the body of the evidence. Despite the interruption that occurred during the pilot SMA
intervention and the impact it had on the attendance of the SMA sessions, the mean HbA1c still
improved. Some of the patients’ HbA1c did not improve or slightly improve; this can be
attributed to the clinic closure announcement that lead to some of the patients to seized attending
the SMA sessions. The results of this intervention should, therefore, pave the way for adoption of
SMA as the standard of care for management of patients with diabetes.
Role Impact Plan
The role of Doctor of Nursing Practice (DNP) is important in every aspect of
contemporary healthcare delivery. Collaboration is an important concept in healthcare. To
achieve the desired system and patient outcomes, DNP must form strategic partnerships with
other members of the healthcare team to manage interdependent and interdisciplinary
relationships. DNP role requires the socialization and interpersonal skills to establish strong
foundations for collaboration, negotiation, consultation, and clinical leadership. (Smith, Vezina,
& Samost, 2013). For the DNP role to have a meaningful impact that improves outcomes,
collaboration must be one of the key pillars of the practice. Collaboration means to work together
in a joint intellectual and the qualities includes: common focus, recognition of one another’s
expertise, and collegial exchange of ideas and knowledge (Smith, Vezina, & Samost, 2013). The
qualities of collaboration and negotiation are therefore necessary for the DNP role to have impact
in healthcare.
My current organization has strong structures in place that are favorable and will enable
the DNP to disseminate EBP within the organization. It has an office that deals with emerging
EBP and research studies and incorporates these findings into standard of practice. Presenting the
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EBP findings to this department will increase the chance of adoption of SMA as the standard of
care for diabetes management across all the clinics within the system.
The DNP growth in my current organization in recent years is notable. This organization
went through a recent restructuring regarding Advance Practice Providers (APP) practice. New
roles where created for leadership in the community outpatient primary care (COPC) for APP
practice. Now most of the COPC clinics are led by APPs. Initially, this organization did not have
such structures in place. Advance Practice Registered Nurse (APRN) counsel and the office of
evidence-based practice are also led by DNP and PhD prepared nurses. DNP foundation in this
organization is, therefore, on a strong footing and expected to grow significantly in the coming
years. The weakness of the role of the DNP in this organization is that there is no specified role
other than leadership for the DNP prepared APP who is on the floor seeing patients. There is an
opportunity that can be seized to create a specified role for the DNP prepared APP such as the
leader who directs all the care and promote evidence-based practice. There are also no monetary
incentives for obtaining a DNP as an APP on the floor. If organizations do not have incentives
to encourage APPs to go back to school to get DNP, the number of APPs who will go back to
school to get a DNP degree will drop significantly. This threat needs to be considered with
seriousness. Achieving a DNP degree requires significant financial and other resources. If
APRNs sense that there is no incentive, then they will not be compelled to get the degree.
Discussion of Project Sustainability Plan and Healthcare Policy
Sustainability is a key part of the EBP process. If the gains that have been achieved
during the implementation cannot be sustained, the whole exercise becomes futile. Using
evidence-based models can help achieve sustainability in EBP. One such model is the ARCC
model. The basic premise of this model for sustainability is: Barriers to EBP must be removed
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and replaced with facilitators, for clinicians to adopt evidence-based practice, their beliefs about
value of EBP and confidence must be strengthened, and EBP culture that includes mentors is
necessary to sustained EBP in healthcare systems (Melnyk, Fineout-Overholt, Gallagher-Ford, &
Stillwell, 2011).
Sustainability of an intervention that has shown to improve health outcomes is important
to the overall health care delivery. SMA has shown to save cost and improve outcomes for
diabetes patients. Therefore, sustainability of this evidence-based practice intervention is
paramount. SMA does not only increased revenue for a healthcare organization, but it can also
reduce the cost of healthcare spending. A provider can see up 10- 15 patients in a 90-minute
visit, versus seeing four patients in traditional clinic visit. Seeing more patients in clinic
translates to more revenue. SMA can also help improve outcomes for diabetes patient, reducing
the number of times they seek care to the emergency room which is expensive. If seeking care to
the ER can be avoided, healthcare cost can be reduced. Moreover, keeping diabetes patient
healthy and avoiding complications also means no missed work days due to diabetes, and
therefore no lost income.
Healthcare access is an important first step in improving outcomes. Access is the ability
to obtain needed, affordable, convenient, acceptable, and effective healthcare in a reasonable
time frame (Damron, Chapman, & Outlaw, 2016). Despite the passage of the Affordable Care
Act (ACA), access remains a challenging problem for some patients, especially the underserved
community. Under the ACA, states are supposed to expand Medicaid to improve access to more
people. However, some states refused to expand Medicaid leaving some of the patients who need
access to health care without any health coverage. Expanding care to more patients through
health care policy changes which can be achieve through legislation, will ensure that EBP
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interventions such as SMA are sustained and continue to improve outcomes. It is morally and
ethically wrong to not extend an effective intervention to all patients that can benefit from it.
Improving access to healthcare will ensure that delivery of healthcare is improve as well.
Health policy is an important process which nurses need to get involved in every step of
the way. It includes all the activities that are involved in policy design, including those activities
that design to lobby legislators or policy makers (O’Grady, 2015). The first step in in
development of a policy that will impact sustainability of my project is to present the evidence to
the policy makers. Policies that will help the sustainability of SMA at local level, can be in the
form of expanding care in local, national and global levels. For example, since Texas did not
expand Medicaid, one can argue and present the evidence that expanding care will help improve
care and save cost. At a national level, congress can strengthen the ACA which already has
structures in place to increase access to care. At global level, organizations such as WHO can
design policies such as programs that will help extend access to care for people who lack access.
Once care access is increased at all levels, then more diabetic patients will have care through
different innovative ways such as the SMA. This will help sustain the SMA and continue to
improve outcomes.
Implications for EPIP Results
The findings from the implementation of SMA suggest that the concept of diabetes
management in a group setting has had a positive effect on the health outcomes of diabetes
patients. As suggested in the body of the evidence and seen during the implementation, SMA
has the potential to improve the efficiency of healthcare providers. This also helps practices
generating more revenue, which in turn help organizations to meet their budget objectives.
Patients also have the additional benefit of longer visits with primary care provider and learning
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and receiving support from peers with the same diagnosis. The results are also a testament that
Advance Practice Nurses can independently design and implement evidence based innovative
projects that can improve the health of our patients and the community as whole.
Key Lessons learned from EPIP Implementation
The three key takeaways from this project implementation are: 1) The project manager
must be ready to respond to unanticipated problems and a plan put in place to mitigate those
unforeseen issues 2) if one follows the interventions as stipulated in the body of the evidence,
one may also expected to get results similar to those represented in the body of the evidence 3)
EBP interventions can improve patient outcomes.
Many aspects of SMA implementation went well; and some did not. This is to be
expected with any EBP implementation. The clinic closure in the organization where I
implemented the SMA affected my project immensely. Therefore, this aspect of the
implementation did not go well. If I can repeat the implementation at another site, I will be more
selective of the location to be assured that the project will not be interrupted in the middle of
implementation. In terms of what went well, I followed the interventions from the body of the
evidence, and I achieved the results represented in the body of the evidence. I also followed the
project implementation plan, even though I had to make some adjustments due to the clinic
closure.
The intervention of the SMA pilot revealed some findings that raised questions that need
to be further pursued for answers. For example, one participant consistently attended the sessions
and has seen a significant drop in his HbA1c. However, some of the other patients who attended
fewer sessions also seen an improvement in outcomes. A question that arises from this is that
how much dose of SMA is needed to achieve improved outcomes? A well design quantitative
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study might be needed to answer this question. This will be important for practice because if for
example four weeks of SMA is as effective as three months of SMA, then utilizing four weeks of
SMA will help save time and resources.
Conclusions
Based on the results of both the pilot and retrospective chart review, SMA is an effective
and innovative intervention that has demonstrated improvement in hemoglobin A1c, blood
pressure, lipid values body mass index and knowledge, compared to individual visits
Dissemination Plan
Dissemination of evidence is an important part of the EBP process. Sharing information
that can improve patient outcomes is not only a responsibility of the scholar, but also moral and
ethical responsibility. Newly discovered evidence will not achieve its maximum value and
improve outcomes unless it is disseminated through a medium that can reach wider target
audience (Betz, Smith, Melnyk, & Olbrysh, 2015). Dissemination of the evidence findings will
be in form of power point presentations, poster, and manuscript. Another plan that is
consideration is poster or PowerPoint presentation that is delivered via podcast or posted in
Google Scholar. This will reach a wider national audience of clinicians. Another advantage of
this is also once the content is archived, it can be used by clinicians any time at their convenience
(Betz, Smith, Melnyk, & Olbrysh, 2015).
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Appendix A: Systematic Search Results

CINAHL= 19
PubMed= 11
Cochrane = 12
Total= 42

27 total articles excluded
due to:
Duplicates
Study protocol
Not relevant to the topic

Final studies included in the
review was 15
2 level 1
5 level II
6 level III
1 level IV
1 level VII
Figure 1.0. Systematic Search results showing final yield of research studies
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Appendix B: Evaluation Table
Table A
Evaluation Table Showing Research Studies
Citation:
author(s), date
of publication&
title

Purpose of
Study

Riley, B.,S.
(2012). Imp.
diabetes
outcomes by an
innova. group
visit model: a
pilot study.
JAANP, 25 (9).

To develop
SMA model
that improves
Hgb A1C
results, BP,
lipids,
depression,
and
satisfaction
among PT.
with DM that
can be used in
PC.

USA

Concept
ual
Framew
ork
TTM
(Stages
of
change
theory)

Design/
Method

Pilot study
pre/post test
Intervention:
Method:
Interactive
SMA SMART
board. and
hands on
activity.
Duration: 2 hrs
1st hour for
group activities
2nd hour for 1on
1 visit with NP.
Program:
monthly X 3
# of PT per
session: 4-20
Staff: NP, MA

Sample/
Setting

N= 22 adult
PT who all
had DX of
DM with
A1C 7.5 or
>, with 80%
of them
females and
32% were
black.

Setting:
Private 4
provider FP
in rural area

Major
Variables
Studied and
Their
Definitions
IV: SMA
(SMART
board , an
interactive
electronic
white board
was utilized
for teaching)
DV:
DV1:HgbA1c
DV2: Wt.
DV3:,BP
DV4: Lipids
DV5:
Depression
DV6: Patient
Satisfaction

Measurement
of Major
Variables

Data
Analysis

Study Findings

P value
DV1- %
reduction
DV2- Scale
DV3- BP
machine
DV4-lab
DV5: BDI
DV6: SOSQ

DV1= ↓ A1c
MR= 1.1 points
(p=0.009)
DV2= 3.01lb MR
(p=0.001)
DV3= DBP ↓ by
a mean of
5.76mmhg (p=
0.002)
DV4= LDL
(p=0.747) not
statically
significance
DV5: Depression
(P=0.045)
DV6: PT
satisfaction
(P=0.028)

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Weakness:
•
Small sample size
•
Non RCT
•
Lack of uniform representation
on race
•
Short duration(Pilot)
•
Names of instrument used for
measurement not provided
Strengths
•
Level III evidence
•
Significant improvement in
DVs
Conclusion:
SMA reduces A1c, BP Wt.; Lipids ↔;
depression improved and PT satisfaction
↑
Risk/Benefit: Benefits of the study
outweigh risks
Recommendations:
•
Level III study, and the findings
agree with higher level studies.
•
But it was a pilot study.

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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SMA technique:
(MM, DSME,
PS)

Watts et al,
(2015). SMA for
PT with DM:
Glycemic
reduction in
high-risk
patients.
JAANP, 27 (8).
450-456.

USA

To assess the
impact of GC
by measuring
A1C in a PC
urban VA
SMA

None

DSME
curriculum: diet,
exercise,
medication,
complications,
health coping
Retrospective
pretest/posttest
study.
Method:
Data was
extracted from
hosp. EMR and
registry.
Patients served
as their own
control, A1c
levels were
averaged for
PTs who
attended SMA
from 4/06 to
12/10.

N=1290 PT

IV: SMA

DV- HgbA1C=
% reduction,

DV: Hgb A1c
96% of them
males.
All the PT
were
recruited at
the VA and
had DX
T2DM and
at high risk
for CM
(A1C >9 and
SBP>160m
mhg)
Setting:
Clinic
(Lours
Stokes

DS-DSI

Paired t
test was
conducte
d for PT
who had
at least
one A1c
measure
ment in
the 180
period .

DV; Hgb A1c
↓(1%) overall
(n=1170)
Linear regression
analysis showed a
significant (p
=0.001) pre-SMA
positive trend
(r2=0.90)
DSI ± 3.01

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Recommend cation and gather
more information before using
as the standard of care

Weakness:
•
Single site study
•
Pretest/post-test design and
lacked control group
•
The number and timing of A1c
measurement varied widely
Strengths:
•
Longitudinal study
•
Large sample size of
1290patients
•
Positive sustainability > 4years
•
Intervention reduce over 9% of
A1c
•
Level III evidence
Conclusion:
A1C ↓ in high risk diabetic PT
Risk/benefits: Benefits outweigh risks

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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Cleveland
VA MC)
Attrition=N
R

Jessee et al,
(2012)
Effectiveness of
NP coordinated
team GV for
T2DM in MU
Appalachia.
JAANP, 24, 735743.

USA

Effectiveness
of
multidisciplina
ry NP
coordinated
team SMA in
MU area on
health, SE, and
knowledge of
PT. with
T2DM.

Bandura
’s (1977)
model of
selfefficacy

Quasi
experimental
study
Convenience
sample.
Subjects were
assigned to
comparison or
study group
Intervention:
SMA method:

Inclusion
criteria:
subjects age
21 and older
with
diagnosis of
T2DM and
A1C of >7.
N=11(NPCT
)
N= 15
(IMA)

Duration: 4
hours
# of PT per
session: 11
Curriculum:
Visit#1:

IV1: was
called “type
of care”.
Intervention
group
participated in
NPCT group
visits
integrating
DSME and
MM with
team
approach.

DV1-mean
reduction
DV2-%
reduction
DV3-mean ↑
(UMDRTC)
DV4-mean SE
(DESSF)

Mean
comparis
ons of
the
groups
pre/post
blood
sugars,
A1c ,
knowled
ge and
selfefficacy

DV1= Study
group’s averaged
post BS ↓
27.24mg/dl more
DV2= Average
post A1c ↓ 0.8%
> the comparison
group.
DV3= Mean post
knowledge ↑
DV4= SE scores
↑ 1.26 points

IV2: IMA
Exclusion:
Being <21,
no T2DM,
or A1c <7

DV:
DV1: BS
DV2: A1c
DV3:
knowledge,
DV4: SE

A1c improved
2.0% in the study
group, but only
0.9% post
intervention in
the comparison

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Recommendation:
•
Level III evidence and
longitudinal study.
•
Findings agrees with higher
level studies
•
Will recommend as the
standard of care
Weakness:
•
Non-randomization of the
subjects
•
Small sample size
Strengths:
•
Level III evidence
•
Noted improvement in all the 4
variables measured
•
Experimental study with
intervention and comparison
groups
Conclusion:
SMA ↓ A1C and BS, knowledge, and SE
↑
Risk/Benefit: Benefits outweigh risk
Recommendations:
•
Level III evidence that agrees
with level I and Level II
studies.

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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DM Overview
Nutrition
BM, stress,
coping, SE,
goals, planning,
medications (1
hr)
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Attrition=N
R
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of Major
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group, with 1.1%
difference. SE
scores improved
0.49 points more
than CG

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
•
Recommend as the standard
of care

Visit#2
Visit to grocery
store, food
labels, food
purchases, food
alternatives
Visit#3
Foot care,
nutrition,
progress and
goal review,
medications
Program:
Weekly X 3
Staff:
Faculty Advisor
Dietician
Pharmacist
Counselors
Nurse
MD
Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
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title

Reitz et al,
(2012). The
effects of SMA
program on
outcomes of DM
care in an urban
family practice.
Journal of
Urban Health,
89 (4). 709-716.

USA

Purpose of
Study

To evaluate
the effect of
DM support
and education
SMA program
on the
achievement
of Hgb A1c ,
LDL, and BP,
and on Wt.
changes
several months
after the
program
began.

Concept
ual
Framew
ork

None

Design/
Method

SMA technique
(MM, DSME,
PS)
None RCT
matched
controlled pre
and post- test
study.
Method:
Baseline
variables
collected for
both groups,
and compared to
7 months F/U
data

Sample/
Setting

PT at least
18 years of
age,

IV1: SMA

DX of
T2DM,

DV:

At least one
visit to the
practice
between
2008-2009.
N=52(SMA)

Intervention:
SMA method:

N=236(IMA
)

Duration: 3
hours

Setting:
Clinic
(Jefferson
Family
Medicine)

# of PT per
session: Not
stated
DSME
Curriculum:
Diabetes

Major
Variables
Studied and
Their
Definitions

IV2: IMA

Measurement
of Major
Variables

DV1-CMH
DV2-propotion
DV3- CMH
DV4-Propotion

Data
Analysis

Cochran
Mantel
Haenszel
(CMH),
P value

DV1: Hbg
A1C
DV2: LDL
DV3: BP
DV4: Weight

Study Findings

DV1 =↑
proportion of pts
who met target
A1C
<7(CMH=4.6613,
p=0.0309), Hgb
A1c ↓ 76.9% of
the participants in
the SMA
compared to
54.3% in the
comparison group
(CMH=8.9911,
p=0.0027)
DV2= No
statistical
significance
achieved
DV3= ↓BP
<140/90(CMH=5.
61, p=0.018)
compared to the
comparison
group.

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Weakness:
•
Lack of randomization
Strengths:
•
Level III evidence
•
Multiple ethic representation
•
Positive improvement in DV
•
Control group
Conclusion:
•
SMA improved patient
management of diabetes

Risk/benefits: Benefits outweigh risks
Recommendation:
•
Level III evidence that agrees
with level I studies
•
Recommend as the standard of
care

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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Complications
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Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

DV4= wt. loss
was similar
across the groups

Program:
4 weeks
Staff:
DE
Nurse
Pharmacist
Provider
SMA technique:
(MM, DSME,
PS)
Caballero et al,
(2015). Effect of
group medical
appointments on
GC of PTs with
T2DM. SD, 28,
(4).245-250

Evaluate
effect of SMA
on A1c

None

Cohort Study
Design
Method:
Retrospective
electronic chart
review
Sample: N=104
male PTs with
T2DM.
Intervention:

Total sample
N=104
SMA:
52/1245
randomly
selected .
Control:
52/352
randomly
selected .
Inclusion for
intervention:

IV1: SMA:
IPP team
evaluation +
Education
IV2:
Individual
visits by PCP
DV: Hgb A1c

DV- Hgb- %
proportion
target A1C
goal

Pearson’
s X2,
P value

IMA cohort rate
of ↓ in A1c (0.001% per week
P=0.912),
X2=0.012

Weakness:
•
Retrospective design without
randomization
•
All male subjects in single
clinical site

SMA cohort rate
of ↓ in A1c over
time (-0.031%
per week,
p<0.001),
X2=45.679.

Strengths:
•
Intervention and control group
compared.
•
Level IV evidence
•
Records were randomly
assigned

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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USA

Purpose of
Study

Concept
ual
Framew
ork

Design/
Method

SMA method:
Duration: 1.5
hours
# of PT per
session: 8-15
Program: 12
months
DSME
curriculum:
Diabetes
Nutrition
Exercise
Medications
Psychosocial
LSM
Staff:
NP
Pharmacist
Nurse
Health Psychologist

Sample/
Setting

T2DM A1c
>8.0, took
part in SMA
within last
12 months.
Inclusion for
control:
T2DM, seen
by PCP
within last
12 months
Setting:
OPC (VA
Loma Linda
Healthcare
system and
its CBOCs)

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

The difference in
the rates of ↓
between the SMA
and IMA cohorts
was significant
(p=0.003).

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
•
Positive findings from the
intervention
Conclusion:
•
50% of SMA versus 19.2% IMA
PT reached target A1C goals.
•
SMA PT had faster rate of A1C
↓ than IMA.
Risk/benefits: Benefits outweigh risk
Recommendation:
•
Level IV evidence that agrees
with high level studies.
•
Recommend as the standard
of care

Attrition:
NR

SMA technique:
(MM, DSME,
PS)
Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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Purpose of
Study

Edelman et
al,.(2014) SMA
for PTs with
DM: A systemic
review. Jour. of
Gen. Inter.
Med.,30 (1) 99106.

SR of the
existing
literature on
SMA
interventions
for PTs with
DM in order to
understand
their impact on
outcomes

USA

Concept
ual
Framew
ork

None

Design/
Method

SR of existing
literature on
SMA
Searched 5
database:
MEDINE,
EMBASE,
CINAHL,
PsycINFO and
web of science.

Sample/
Setting

N=1172
citations
MEDLINE
(n=397),
CINAHL
(n=290),
Embase
(n=145),

Publications
from January
1996 through
April 2012, to
compare SMA
with IMA.

PsychINFO
(n=157)

Inclusion: Of 17
total studies, 13
RCTs, 4
observational
studies

Manual
search (n=2)
a total of
1174
citations.

SMA
techniques
across studies:

Inclusion
and
exclusion

Web of
science
(n=186)

Major
Variables
Studied and
Their
Definitions

IV: SMA
DV:
DV1:HgbA1c
DV2: BP
DV3:
Cholesterol

Measurement
of Major
Variables

DV1: %
reduction
DV2: mean
reduction
DV3: Mean
reduction

Data
Analysis

Forrest
plot,
Mean,

Study Findings

DV1=SMA ↓
A1C (∆ =-0.55 %
(95% CI, -0.11 to
-0.99)
DV2= ↓ SBP
(∆=-5.2mmHg
(95% CI, -3.0 to 7.4)
DV3= (∆=-6.6
mg/dl) (95% CI
2.8 to -16.1) LDL
↓ but not
statistically
significant
A1C result had
significant
heterogeneity
among studies.

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Weakness:
•
Heterogenicity among the
components of diabetes SMAs
leads to uncertainty about what
makes a particular SMA
successful
Strengths:
•
Systemic review with metaanalysis of RCTs and
observation studies
•
Level 1 evidence
Conclusion:
•
SMA improved biophysical
outcomes among patients with
T2DM.
•
Inadequate data to determine
the effect on PT experience,
utilization and cost.
Risk/Benefits: Benefits outweigh risks
Recommendations:
•
SMA is feasible in practice
•
Level I evidence, will
recommend as the standard of
care

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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Design/
Method

MM, DSME, PS
# of PT per
session:
6-10 (n=10)
10-20(n=5)
25 (n=1)

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

lead 17
studies
Poor
glucose
control
(from
A1c6.5-9%)

Visit frequency:
3 weeks -3
months
Duration:
medical of 2
hours (range 1
to 4hr)
Staff:
MD (n=13)
Pharmacist
(n=9)
Nurse (n=10)

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Housden et
al,(2013)
Effectiveness of
SMA for
improving DM
care: a SR and
meta-analysis.
Cana. Med.
Asso. Journal,
185(13). E635E64.

SR and metaanalysis of the
evidence on
effectiveness
of SMA for
patients with
DM

Concept
ual
Framew
ork

None

Design/
Method

SR of RCT and
observational
studies.
Meta-analysis
studies
published
between 1947 to
February 2012.

Sample/
Setting

N=28 ,347
identified
through
database
search,
n=92(abstrac
t + title
review)

Literature
search was
conducted using
MEDLINE,
CINAHL ect,.

n=62
(articles
identified for
full text
review)

94studies
identified 26
selected, 13
were RCT

n=36
(studies
excluded
after full text
review)

USA

n= 26
(studies that
was
selected)
n= 13 (
RCT)

Major
Variables
Studied and
Their
Definitions

IV: SMA
DV:
DV1:Hgb
A1c
DV2: BP
DV3:
Cholesterol
DV4: Weight
DV5: BMI

Measurement
of Major
Variables

Weighted
mean
difference
% reduction in
A1C

Data
Analysis

Data
from
RCT was
analyzed
using
Review
Manager
software
(RevMan
. Version
5.1
Nordic
Cochran
e center).
A X2 for
heteroge
nicity
was
used.

Study Findings

DV1=PTs
attending SMA
(weighted mean
difference (0.46%, 95% CI 0.80 to -0.31)
DV2= -2.81%,
95% CI (-6.84 to
1.21)
DV3: 0.04%,
95% CI (-0.21 to
0.30)
DV4:-0.50%,
95% CI ( -3.87 to
2.88)
DV4: 0.05%,
95% (-0.90 to
1.00)

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Weakness:
•
Few long-term studies in the
review.
•
Search restriction to published
studies only
•
Articles written in English only
were included
Strengths:
•
Systemic review of RCT and
observational studies
•
Level I evidence
Conclusion:
•
SMA reduced hemoglobin A1C
for T2DM.
•
Wider implementation of SMA
will have positive impact on
patient outcomes.
Risk/Benefits: Benefits outweigh risk
Recommendation:
•
SMA should be implemented
in practice to improve
outcomes for T2DM PT
•
SMA is feasible in practice
•
Level I evidence, we should

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Ridge, T. (2012)
shared medical
appointment in
diabetes care: A
Literature
review.
Diabetes
Spectrum, 25
(2), 72-75.

Literature
review of RCT
and non-RCT
studies

USA

Concept
ual
Framew
ork

None

Design/
Method

Evidence
review, how the
studies were
chosen was not
stated

Sample/
Setting

7 RCT , and
2 non RCT
were
included in
the review.

Major
Variables
Studied and
Their
Definitions

Variables
reviewed in
the studies:
IV; SMA

Measurement
of Major
Variables

Not stated

Data
Analysis

Not
stated

Study Findings

The review of the
different studies
concluded that
SMA was
effective in
reducing HgbA1c

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
use this as the standard of
care.

Weakness:
•
Level VII evidence
Strength
•
RCTs included in the review

DV: Hgb A1c
•

Conclusion: SMA have
demonstrated effectiveness in
improving knowledge, quality
of life, and problem-solving
skills related to diabetes

. Risk/Benefits: Benefits outweigh risk
Recommendation:
•
Level VII evidence, but in
agreement with higher level
studies,
•
Will recommend with caution
as the standard of care

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Berry et al,
(2016).
Imbedding
interdisciplinary
diabetes GV into
a communitybased medical
setting. The
DEr, 42 (1), 96107.

To evaluate
an
interdisciplinar
y approach
and test the
efficacy of
diabetes SMA
tailored to
low-income
PTs in a
community
based medical
practice

USA

Concept
ual
Framew
ork

None

Design/
Method

RCT
• Method:
Intervention
group -5
diabetes SMA
sessions, 1
every 3 months
X15 months
Control group 5
individualized
sessions, 1
every 3 months
X 15 months
with PCP.
Intervention
SMA method:
# of PTs per
SMA session:
40

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

N=80
n=40 Pts for
intervention
group
n=40 control
group

IV1 : SMA

Inclusion
criteria:

DV2: Lipids

IV2: IMA
DV1:
HgbA1c

DV3: BP
• age: 18 <,
• speak, read
and write
English,
• primary
care from
Alliance
Medical
Ministry,
• A1c > 8%.

Duration: Not
stated

Setting:
Clinic
(Alliance
medical
ministry)

Program:

Attrition: 12

Measurement
of Major
Variables

DV1: %
reduction
DV2: %
reduction
DV3: mean
reduction
Dv4: mean
reduction

Data
Analysis

p-value

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

DV1=
Intervention
group A1C ↓ by
1.2% to 7.6%
(p=0.001);

Weakness:
•
Single site study
Strengths:
•
Level II evidence
•
Ethnic diversity

Pts in the control
group ↑ their A1c
by 1.3 percentage
pts to 9.3% at
time 5.

Conclusion:
•
Diabetes group visits which
included DSME and a medical
visit with healthcare provider
improved A1C.

DV4: HR
DV2= Lipids ↓ in
intervention
group
HDL(P=0.033),
Triglycerides
(p=0.033)
DV3= BP ↓ by
time by
time5(15months)
DV4=HR ↓ by
time 5 (15
months)
(p=0.031)

Risk/Benefits: Benefits outweigh risks
Recommendation:
•
SMA is feasible and practical to
implement is practice
•
SMA can be implemented to
help ethnically diverse low
income working full time PT to
improve A1C
•
Level II evidence that agrees
with higher level studies
•
Will recommend as the
standard of care

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Concept
ual
Framew
ork

Design/
Method

15 months
Staff:
NP
MD
Nurse
Dietician
Exerciseeducator
Clergy

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

(finding from
study, HR was
never elevated)

DSME
curriculum:
Diabetes
Foot care
BGM
Blood pressure
Lipids
Nutrition
Exercise
Complications
SMA technique:
MM
individually
DSME and PS
in group

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Guthrie et al,
(2015). Impact
of a SMA life
style
intervention on
Wt and lipid
parameters in
individual with
T2DM: A
clinical pilot.
Journal of
Amer. Coll. of
Nut., 34 (4) 300309.

To evaluate
the
effectiveness
of a DM
educational
program
combining
SMA with 8
week DVD
based DM
education
program
emphasizing a
plant based
diet in
lowering Wt.
and lipids in
individuals
With T2DM

USA

Concept
ual
Framew
ork

None

Design/
Method

Sample/
Setting

A pilot
nonrandomized
own-control
study

Nonrandomized
convenience
sample

Method:
Procedures:
16 SMA
sessions

Own-control

Major
Variables
Studied and
Their
Definitions

IV: SMA with
DVD video
DSME
DV:

Intervention:
SMA method:
Duration: 90120 minutes
Program: SMA
with 8week
biweekly DVD
video DSME
Staff:
Medical
provider,
Resident
DSME video
presenters(MD,
dietician,

N= 46
participated
in the WSDP
program.

DV1:
Cholesterol
DV2: LDL
DV3: HDL

Attrition:
N=2
Setting:
Clinic (
Family
medicine
practice in
Orlando,
FL).

DV4:
Triglycerides
DV5: Weight

Measurement
of Major
Variables

DV1: MC
DV2: MC
DV3: mean
changes
DV4: MC
DV5: MC

Data
Analysis

Paired ttest

Study Findings

DV1= Total
cholesterol ↓ (6.20mg/dl) t=
1.01
DV2=LDL ↓ (6.43mg/dl) t=1.31
DV3=HDL= ↑ (1.98mg/dl) t=1.55
DV4=
Triglycerides ↓ (-2.39mg/dl)
t=0.24
DV5= Weight ↓
Significantly
(mean of -8.90lb)
t=7.05, p<0.05)
Improvements
seen in LDL,
HDL, cholesterol
and triglycerides,
but did not reach
statistical
significance.

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

Weakness:
•
A pilot study
•
Convenient sample
•
No randomization
•
No control group
•
Small sample size
Strength:
•
Level III study
•
Measured variables improved
Conclusion:
•
DVD based DSME delivered as
part of SMA was associated
with significant Wt. loss.
•
Behavior changes most closely
associated with weight loss
were ↑ water intake,
eliminating evening meals, and
increasing the consumption of
beans for breakfast.
Risk/Benefits: Benefits outweigh risk
Recommendation:
•
Level III evidence, agrees with
higher level studies
•
Will recommend as the

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Concept
ual
Framew
ork

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

exercise
physiologist)

Note:
SMA session flow

# of PT per
session: Not
stated

Vital signs, behavior reporting form
completion =10 t0 15 minutes

Video DSME
curriculum:
Exercise
Nutrition
Diabetes

DVD video lecture. Exercise, and
nutrition, and diabetes management: Data
recorded in the EMR= 45 to 50 minutes
Questions and answer session= 10
minutes

SMA technique:
MM, PS,
DSME(video)
Liu et al.,
(2012). Effe. Of
using SMA to
sup. DM PT
self-mgt in rural
comm. Of
Shanghai> RCT.
BMC Pub
Health 12, 1043

To develop
SMA program
and examine
its
effectiveness
on SMB, SE,
HS for PT
with T2DM.

The
Coopera
tive
Health
care
Clinic
model

RCT.

N=208

IV1: SMA

Intervention(n=
119)

I-(n=119)

IV2: IMA

C-(n=89)
Inclusionmen and
women 3580 with
T2DM

DV1: SMB
DV2: SE
DV3: HS
DV3a: SBP
DV3b: BMI

Control(n=89)
IMA for 12
months
SMA Method:
Intervention:
Program:
12 SMA
sessions for 12

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
standard of care.

Exclusionage <35 and
>80

SMBquestionnaire
SE-SE Chinses
version of 8
item DM Se
scale
developed by
Stanford
patient
education
research center
HSQuestionnaire

MC
SD
P value

DV2:
Intervention
group ↑ of 0.71 in
mean SE
score(p=0.02)

Shared medical appointment with each
participant= 45 to 60 minutes
Weakness:
•
Mostly older patients with
higher prevalence of disease
•
15% of subjects did not
complete the study
•
Small sample size
Strengths:
•
RCT
•
Lasted 12 months

DV3:
Intervention
group had
significant

Conclusions:
•
Chines diabetes SMA model
was feasible acceptable and
effective alternative for

DV1: ↑ Aerobic
exercise by > 40
minutes per
week(P=0.001)

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Concept
ual
Framew
ork

Design/
Method

months X
monthly
Duration: 1.5
hours
Staff:
Provider
Nurse

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

Setting:
Rural area in
Shanghai

improvement in
measures of
illness and SBP.

Attrition:
I=21:

DV3a=3.72mmH
g ↓ on average.
(p=0.04)

moved out
(n=10)

DSME
curriculum:
Diabetes
Nutrition
Exercise
Foot care
Medication

Died(n=3)

SMA technique:
MM separated
from group.
DSME and PS

C=11:
moved out
(n=4)

Refused
(n=2)
Unknown
(n=6)

DV3b= ↓
0.28kg/m^2
(P=0.22)

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
providing self-management
support to PT with T2DM in
Chines rural communities
Risk/Benefits: Benefits outweigh risk
Recommendation:
•
This model of SMA is feasible
and should be implemented in
practice to improve diabetes
outcomes
•
Level II evidence that agrees
with higher level I evidence
•
Will recommended with
caution because the study did
not measure A1C. More
information is needed

Died(n=2)
Refused
(n=3)
Unknown
(n=2)

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title
Cole et al.,
(2013) Eff. Of
prediabetes
nutria. SMA.
Diab. Edu.
39(3).

Purpose of
Study

To evaluate
nutrition based
SMA
intervention in
treatment of
prediabetes
compared to
individualized
counseling

Concept
ual
Framew
ork
None

Design/
Method

RCT
Nutrition
SMA(I), and
individualized
counseling (C)
Method: SMA
group attended
three 90 minutes
nutrition SMA,
Control group
attended 60
minutes IMA
registered
dietician.
SMA method:
Nutrition based
SMA
Duration: 1.5
hours
Program:
Monthly SMA
X3 months
# of PT per
session: 6-8

Sample/
Setting

N =94

Major
Variables
Studied and
Their
Definitions
IV: Nutrition
SMA

I-(n=34)
C-(n=31)
Inclusion:
≥18 years of
age, English
speaking and
Dx of
prediabetes
Exclusion:
Dx of
diabetes

DV1: FBG
DV2: A1C
DV3: WT
DV4: BMI
DV5: BP
DV6:
Cholesterol

Measurement
of Major
Variables
FBG- MC
A1C- MC
Wt- MC
BMI- MC
BP- MC

Data
Analysis

Study Findings

Mean ±
SD
ANOVA

Outcome at 3
months compared
to baseline:
Repeated
measures
ANOVA within
group (P<0.05)
SMA(n=34)
DV1: -6±9
IMA (n=31)
DV1:-6±15
SMA(n=34)
DV2: (0.1±0.4)

Setting:
Enrollees of
TRICAR
health care
system

IMA (n=31)
DV2: 0.4± 1.1

Attrition:
n=29

IMA (n=31)
DV3 -1.6± 3.3

SMA (n=34)
DV3: -3.0± 3.0

SMA (n=34)
DV4: -1.0±1.1
IMA (n=31)
DV4: -6.6± 1.2

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Weakness:
•
High attrition rate
Strengths:
•
RCT
•
Long duration
Conclusion:
•
SMA outcomes yielded a
greater degree of
improvements than the control
group
•
SMA is equivalent to individual
appointment to support
hypothesis
Risk/benefits: Benefits outweigh risk
Recommendation:
• SMA is feasible and should be
available in practice as an
alternative for patients
• SMA should be implemented in
practice to improve outcomes
• Level II study that agrees with
higher level study
• Will recommended as the
standard of care

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Cohen et
al.,(2011).
Pharmacist-led
SMA for multi.
Cardio. Risk
reduction in PT
with T2DM. The
Diabetes
Educator,37(6)

Purpose of
Study

To assess
whether VA
MEDIC-E, a
pharmacy led
SMA program
could improve
outcomes
compared to
individual
appointment

Concept
ual
Framew
ork

None

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

Staff:
Dietician
DE
Nurse
Behavioral
specialist

SMA (n=34)
DV5: SBP 12±16

DSME
curriculum:
Nutrition
Exercise

SMA (n=34)
DV6: -14±41

SMA technique:
MM, DSME, PS
RCT
I-=VA MEDICE(SMA)
C= (IMA)
SMA Method:
Duration: 2
hours
Program:
SMA (VA
MEDIC-E) 4
once weekly 2
hour sessions,
followed by 5

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

IMA (n=31)
DV5: -12±17

IMA (n=31)
Dv6: -6±24
N=99
VA MEDICE(SMA)
n=50
Individual
apt (Control
) n= 49
Inclusion:
DX of
T2DM, A1C
> 7%, LDL
>100,BP
>130/80
Setting:
Clinic, VA

IV: Va
MEDICE(SMA)
DV1; A1C
DV2: LDL
DV3: SBP

A1C- %
reduction
LDL- MC
SBP- MC

Mean
SD
t-test
percent

DV1: MEDIC
arm achieved
target A1C values
(40.8% vs 20.4%
in control
(p=0.028)
DV2: MEDIC
arm had ↓ of LDL
96.1mg/dl vs
110.7mg/dl in
control (p=0.024)
DV3: SBP
<130mmHg (58%
cases vs 32.7%
control)
(p=0.015)

Weakness:
•
Mostly male veterans
•
Mostly Caucasians
•
Names of some of instrument
not stated
Strengths
•
RCT
•
Multi-displenary
Conclusions:
•
Pharmacist led SMA was an
efficacious and sustainable
•
A collaborative care approach
to managing diabetes to
reduce cardiac risk.

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Concept
ual
Framew
ork

Design/
Method

Sample/
Setting

monthly booster
sessions.

medical
center

Staff:
Pharmacist(prov
ider)
Dietician
Nurse

Attrition n=3
Died(n=3)

DSME
curriculum:
Diabetes
Medication
Stress
Nutrition
Exercise
Foot care

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

At 6 months,
significant
improvements
from baseline
were noted in the
VA MEDIC-E
group for
exercise, foot
care and goal
attainment of
A1C, LDL, and
BP, but not in the
control group

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Risk/Benefits: Benefits outweigh risk
Recommendation:
•
Level II evidence and Supports
the findings of level I evidence.
•
Will recommended as
standard of care

# of PT per
session: 4-6
SMA technique:
MM, DSME, PS
IMA group
attended once
every 4 month
visits

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Tokuda et
al.,(2016). The
Utili. Of videoconference
SMA in rural
diabetes care.
Inter. Jour. Of
Medical
Informatics,93.

To explore the
feasibility of
innovative
modes of care
delivery such
as video-SMA
to improve
DM care at
remote clinical
site

Concept
ual
Framew
ork
None

Design/
Method

Sample/
Setting

Prospective
nonrandomized
study

N=100

SMA Method:
Intervention:
Weekly video
SMA for 4
weeks, followed
by bi-monthly
booster for 5
months

Control(n=6
9)

Intervention(
n=31)

Inclusion:
A1C ≥ 7%

Duration: 2
hours

Setting: rural
community
outpatient
clinic

# of PT per
session: 3-5

Attrition:
NR

Staff:
NP
Pharmacist
DSME
curriculum:
Nutrition
Exercise
Medication
Diabetes
BM

Major
Variables
Studied and
Their
Definitions
IV: Video
SMA
DV1: A1C
DV2: BP
DV3: LDL
DV4:
Triglycerides

Measurement
of Major
Variables
AIC-%
reduction,
BP- MC

Data
Analysis

Mean
±Standar
d Error

Study Findings

DV1: Greater ↓in
A1C was
observed in SMA
group after 1 to 3
months 9.1 ± 0.3
to 8.3 ± 0.3 vs
IMA 8.6 ± 0.2 to
8.7 ± 0.2 (p=0.03)
DV2: SMA group
had significant ↓
in both DBP and
SBP than control
(p=0.04 and
p=0.01,
respectively)
DV3: Baseline
2.4 ± 0.2 vs 5
months, 2.2 ±0.2
(p=0.55)

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
Weakness:
•
No randomization
•
Mostly men
•
Small sample size
Strengths
•
Quasi experimental study
•
A1C significantly ↓
Conclusion:
•
Video -SMA is feasible, well
perceived and has the
potential to improve diabetes
outcomes in a rural setting.
Risk/Benefits: Benefits outweigh risk
Recommendation:
•
Level III evidence that agrees
with level II studies
•
Will recommend as the
standard of care

DV4: Baseline:
2.6 ±0.7 vs 5
months 2.1 ± 2.3
patients in video
SMA group
showed lower
rate of ED visits
relative to the
control group

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.
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title

Purpose of
Study

Concept
ual
Framew
ork

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS

(3.2% vs 17.4%,
p=0.01)

SMA technique:
MM, DSME, PS
Control group
attended IMA
with PCP
Taveira, et
al.,(2011).
Phamarcist-led
SMA for mgt of
DM with
comorbid
depression Ann.
of
Pharmacotherap
y,

The study
sought to
determine
whether SMA
are feasible for
the tx of DM
in patients
with
depression

None

RCT
I=(VA-MEDICD)(SMA)
C=(IMA)
Method:
Program:
SMA VAMEDIC-D
attended 4 once
wkly SMA,
followed by 5
monthly booster
sessions
Duration:2
hours
# of PT per
session: 4-6

N=88
I=VAMEDIC-D
(n=44)
IMA=
(n=44)
Inclusion:
Veterans
with type 1
or type 2
DM with
A1C >6.5
within the
last 6 month
Setting:
Outpatient
clinic

IV= VAMEDIC-D
DV= IMA
(standard
care)
DV1:A1C
DV2: BP
DV3: Lipids
DV4:
Depression

AICProportion of
pt at goal
BP- MC
DepressionPHQ-9 scale

Proportio
n of pt
who met
A1C
goal
OR
PHQ-9
Mean

DV1:
The VAMEDIC-D arm
achieving
guideline
adherence for
A1C was > IMA
(29.6% vs 11.9%)
with OR 3.3(95%
CI 1.0 to 10.0)
(p=0.04)
DV2: BP ↓(IV
mean
123.4mmHg vs
IMA mean
127mmHg(p=0.1
0)
DV3: IV mean
LDL=92.5mg/dl
vs IMA mean
93.9mg/dl)

Weakness:
•
Single site homogenous
population
•
Small sample size
Strengths:
•
RCT
•
Duration of SMA longer than
most
Conclusion:
•
Pharmacist led group SMA
visits are efficacious in
attainment of glycemic control
in patients with diabetes
•
It improved depression
symptoms
Risk/Benefits: Benefits outweigh risk
Recommendation:
•
Level II evidence that agrees
with level I evidence findings
•
Will recommend as standard of

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Citation:
author(s), date
of publication&
title

Purpose of
Study

Concept
ual
Framew
ork

Design/
Method

Staff:
Dietician
Nurse
Provider (
clinical
pharmacist)
DSME
curriculum:
Nutrition
Exercise
Medication
BM

Sample/
Setting

Attrition: 2
lost to f/u, 1
died and 1
nursing
home (hip
fx)

Major
Variables
Studied and
Their
Definitions

Measurement
of Major
Variables

Data
Analysis

Study Findings

DV4: PHQ-9
score ↓ by
50%from
baseline for
45.5% of VAMEDIC-D group
and 34.1% for
IMA
group(p=0.28)

Appraisal of Worth to Practice
Strength of the Evidence (i.e., level of
evidence + quality [study strengths and
weaknesses])
RECOMMENDATIONS
care

SMA technique
MM, DSME, PS
IMA arm
attended regular
visit with PCP
for 30 minutes
with DSME
available to
them 4 once
weekly for 2
hours

Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS=
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator;
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model; LDL= low density lipoprotein; MR= mean reduction;
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation;
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight;
UMDRTC=university of Michigan diabetes research training center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant.

Appendix C: Synthesis Tables
Table B
Level of Evidence of the Research Studies

1

2

3

4

5

Level I: Systemic
review or metaanalysis

6

7

✓

✓

8

Level II:
Randomized
controlled trial
Level III: controlled
trial without
randomization
Level IV: Casecontrol or cohort
study

10

✓
✓

✓

✓

✓

✓
✓

Level V: Systemic
review of qualitative
or descriptive study
Level VI:
Qualitative or
descriptive study
(includes evidence
implementation
projects)
Level VII: Expert
opinion or consensus

9

✓
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11

12

13

✓

✓

✓

14

15

✓
✓

Table C
Effect of Shared Medical Appointment on Patient Outcomes

1

2

3

4

5

6

7

8

9

Hemoglobi
n A1C

↓

↓

↓

↓

↓

↓

↓

↓

↓

Lipids

↓

↔

↓

↓

Blood
Pressure

↓

↓

↓

↓

Weight

↓

↔

10

11

↓
↓
↓

↑

76

13

14

15

↓

↓

↓

↓

↓
↓
↓

Knowledge

↑

12

↑

↓
↓

↓

↓

Table D
SMA duration and frequency

1

2

3

4

Monthly

Weekly

Weekly

How many
minutes per
SMA
session?

2hours

4hours

3 hours

Total
Duration of
SMA
intervention

3
Months

5

How Often?

3
weeks

4
weeks

90
minutes

6

7

3 week
to 3
months

Varied

1 to 4
hours

2 hours
Average

Varied

4
months
to 4
years

8 9
Q3
months

15
months
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10

11

12

13

Biweekly

Monthly

Monthly

WeeklyX4
Then,
Monthly
boosterX5

2 hours

1.5
hours

90
Minutes

2
Hours

12
Months

3
Months

6
Months

8
weeks

14
WeeklyX4,
then, 2 bi
monthly
booster

1.5
Hours

5
Months

15
Weekly
X4, then
monthly
booster
X5
2
hours

6
Months

Table E
SMA Diabetes Curriculum
Diabetes
selfmanagement
strategies

1

Medication
Management √

2

3

4

5

6

7

8

9

√

√

√

10

11

12

√

14

15

√

√

√

√

√

√

Nutrition
management

√

√

√

√

√

√

Exercise

√

√

√

√

√

√

√

√

Behavioral
modification

√

√

√

√

√

√

√

√

√

Foot care

√

√

√

√

√

√

√

√

Diabetes
overview

√

√

√

78

√

13

Table F
SMA Logistics
SMA
Logistics

1

2

3

4

Primary
Care

✓

✓

✓

✓

✓

✓

✓

Group
Support
DM Selfmanagement
education
How many
patients per
Group session
Interprofessional
Team
Nurse
Medical
Provider
Dietitian
Counselor
Exercise
Trainer
Health
Psychologist

4-20

9

10

11

12

13

14

15

Synthesis

✓

✓

✓

✓

✓

✓

✓

✓

12/15

✓

✓

✓

✓

✓

✓

✓

✓

✓

12/15

✓

✓

✓

✓

✓

✓

✓

✓

✓

12/15

11

5

6

7

8

8-15

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓
✓

✓

20-25

6-8 4-6

4-6

4-6

✓

✓

✓

✓

✓

11/15

✓

✓

✓

✓

✓

12/15

✓

5/15

✓
✓

✓
✓

4-6= 3
20-25=1
6-8= 1
8-15= 1
11= 1
4-20= 1

2/15
1/15
1/15
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Appendix D: Match of Plan to Evidence
Table G
Match of Plan to Evidence
Intervention

Evidence

Baseline data will be collected pre/post

1,2,4

SMA will include medical management, peer support and DSME

1,2,3,4,5,9,10,11,12,13,14,15

SMA will be held weekly x4 then booster x2

3,4,13,14,15

SMA will last 2 hours/session with intervention duration of 3
months

1,7,10,12,13,15

DSME curriculum will include: medication management,
nutrition, exercise management, foot care, diabetes overview and
behavior modification

1,3,5,9,10,11,13,14,15

SMA groups per session will include 4-6 patients

1, 13,14,15

The inter-professional team will include at least a medical
provider and a nurse

1,2,3,4,5,9,11,12,13,14,15

Outcome measure will include A1C, BMI, Lipid values, and
knowledge

A1C1,2,3,4,5,9,11,12,13,14,15
Lipid values1,4,6,9,10,12,15
BP- 1,4,6,9,11,12,13,14,15
Weight- 1,4,10,12
Knowledge- 3,8,11
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Appendix E: Intervention Plan
Table H
Intervention Plan
WhenDate

Who

What

Where

How

January 19th,
2018/
Week 0 preimplementation

NP
Registered
Nurse (RN)
Medical
Assistant
(MA)

Staff education/In-service

Clinic nurses
station

March 23rd,
2018/Week 1
implementation

MA

•

Patient
registration

Receptionist desk

Using EPIC EMR

RN

•

Vital signs
including
weight and BP

Group room

Using Welch Allyn Dinnamap

NP

•

Baseline data
collection (
A1C, BP, Lipid
values,
Knowledge )

Group room

A1c, BP, Lipid values, queried from
EPIP EMR and transferred to Excel
sheet

Patient chart
review
Introduction and
Ice breaker
session

Provider office

•
•
•
•
•

NP

•

Patients, NP,
RN, MA

•

NP

•

Medical
management

Group room

NP
RN

•

Diabetes SelfManagement
Education
(DSME)

Group room
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Group room

Presentation,
Logistics/protocol
discussion,
Mock SMA
Resource review
SMA schedule review

Knowledge test was administered
using University of Michigan
Diabetes Research Training
Center(UMDRTC) diabetes
knowledge test
Going through each chart one by
one
Each staff introduced him/herself
and each patient did the same.
HIPPA reminder was discussed
during this session
NP sequentially attended to each
patient in the group starting with
brief medical history first, followed
by brief physical examination and
finally, discussion of the lab results
including hemoglobin A1C and
medication management with the
participation of the group as peer
support. This lasted 5-10 minutes
per patient
Presentation using, pictures,
handouts, and cards. Topic included:
Diabetes overview(basics) including
pathophysiology, acceptable lab
values for A1c, hypoglycemia,
glucose monitoring and
complications; medication
management, nutrition management,
exercise, foot care and behavioral
modification Week 1 education
focused on diabetes overview:
Pathophysiology, and acceptable
values for A1C. ADA professional
resources handouts on diabetes

WhenDate

March 29th,
2018/Week 2

Who

What

Where

How

NP
RN
Patients

•

Peer support in
the group

Group room

NP

•

Visit conclusion
and goals

Group room

MA

•

Receptionist desk

RN

•

Group room

Using Welch Allyn Dinnamap

NP

•

Provider office

Patients, NP,
RN, MA

•

Patient
registration
Vital signs
including
weight and BP
Patient chart
review
Introduction and
Ice breaker
session

pathophysiology and A1C was
utilized. The mode of delivery was
discussion/demonstration/handouts.
This lasted for 60 minutes
Patients asked questions, and they
were also shared their success
stories with their peers in the group.
Patients who were doing well with
meeting their glycemic goals were
praised and were encouraged to lead
the discussion and educate those
who are struggling with meeting
their glycemic targets. Peers
provided support as necessary. This
lasted for 30 minutes
The session ended with each patient
setting a clear achievable goal as to
how they plan to improve their
diabetes management before next
meeting by writing the goal down
on a paper. The session was
adjourned until next week Thursday.
Using EPIC EMR

NP

•

Medical
management

Group room

NP
RN

•

DSME

Group room

Going through each chart one by
one
Each staff introduced him/herself
and each patient did the same.
HIPPA reminder was discussed
during this session
NP sequentially attended to each
patient in the group starting with
brief medical history first, followed
by brief physical examination and
finally, discussion of the lab results
including hemoglobin A1C and
medication management with the
participation of the group as peer
support. Each patients progress was
discussed in the group. Peers
provided support as necessary. This
lasted 5-10 minutes per patient
Presentation using, pictures, and
handouts. Week 2 education focused
on Diabetes overview:
hypoglycemia and glucose
monitoring. American Diabetes
Association (ADA) professional
resource handouts on hypoglycemia
and glucose monitoring. Defining
what is hypoglycemia? What can
you do to avoid it? What are the
signs and symptoms of
hypoglycemia? What are the
complications of hypoglycemia?
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Group Room

WhenDate

April 6th,
2018/Week 3

Who

What

Where

Receptionist desk

What types of food can you eat to
avoid hypoglycemia? This lasted for
60 minutes
Patents asked questions, and they
were also encouraged to share their
success stories with their peers in
the group. Patients who are doing
well with meeting their glycemic
goal were praised and were
encouraged to lead the discussion
and educate those who are
struggling with meeting their
glycemic targets. This lasted for 30
minutes
The session ended with each patient
setting a clear achievable goal as to
how they plan to improve their
diabetes management before next
meeting by writing the goal down
on a paper. The session was
adjourned until next week Friday.
Using EPIC EMR

Group Room

Using Welch Allyn Dinnamap

Provider Office

Going through each patient chart in
EPIC EMR
Each staff introduced him/herself
and each patient did the same.
HIPPA reminder was discussed
during this session
NP sequentially attended to each
patient in the group starting with
brief medical history first, followed
by brief physical examination and
finally, discussion of the lab results
including hemoglobin A1C and
medication management with the
participation of the group as peer
support. Each patients progress was
discussed in the group. Peers
provided support as necessary. This
lasted 5-10 minutes per patient
Presentation using, pictures,
handouts. Week 3 education was
focused on diabetes complications
and medication management.
American Diabetes Association
(ADA) professional resource
handouts on hypoglycemia and
glucose monitoring. We discussed
about oral diabetes medications and
importance of adherence, identifying
the ones that are insulin sensitizers
and the ones that can cause
hypoglycemia. We also discussed
insulin including self-titration using

NP
RN

•

Peer support in
the group

Group room

NP

•

Visit conclusion
and goals

Group room

NP

•

RN

NP

Patient
registration
•
Vital signs
including
weight and BP
Patient chart review

Patients, NP,
RN, MA

•

Introduction and
Ice breaker
session

Group room

NP

•

Medical
management

Group room

NP
RN

DSME

Group room
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How

WhenDate

April 13th,
2018/Week 4

Who

What

Where

How

NP
RN

•

Peer support in
the group

Group room

NP

•

Visit conclusion
and goals

Group room

MA

•

Receptionist desk

RN

•

Group room

Using Welch Allyn Dinnamap

NP

•

Provider office

Going through each patient chart

Patients, NP,
RN, MA

•

Patient
registration
Vital signs
including
weight and BP
Patient chart
review
Introduction and
Ice breaker
session

sliding scale, appropriate injection
sites, and potential for
hypoglycemia. Complications
education will include
macrovascular complications
(coronary artery disease, stroke and
peripheral artery disease) and
microvascular complications
(retinopathy, nephropathy and
neuropathy). This lasted for 60
minutes
Patents asked questions, and they
were also encouraged to share their
success stories with their peers in
the group. Patients who are doing
well with meeting their glycemic
goal were praised and were
encouraged to lead the discussion
and educate those who are
struggling with meeting their
glycemic targets. This lasted for 30
minutes
The session ended with each patient
setting a clear achievable goal as to
how they plan to improve their
diabetes management before next
meeting by writing the goal down
on a paper. The session was
adjourned until next week Friday.
Using EPIC EMR

Group room

NP

•

Medical
management

Group room

NP
RN

•

DSME

Group room

Each staff introduced him/herself
and each patient did the same.
HIPPA reminder discussed during
this session
NP sequentially attended to each
patient in the group starting with
brief medical history first, followed
by brief physical examination and
finally, discussion of the lab results
including hemoglobin A1C and
medication management with the
participation of the group as peer
support. Each patients progress was
discussed in the group. Peers
provided support as necessary. This
lasted 5-10 minutes per patient
Presentation using videos, pictures.
Week 4 education focused on
nutrition management and exercise.
Association (ADA) professional
resource handouts on nutrition
management and exercise. We
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WhenDate

April 20th,2018/
Week 5

Who

What

Where

How

NP
RN

•

Peer support in
the group

Group room

NP

•

Visit conclusion
and goals

Group room

Patients
NP

•

Individual
Medical
Appointment
(IMA)
Patient goals
No Shared
Medical
Appointment
(SMA) this
week
Project
milestone

•
•

•

Clinic

•

Home

talked about carbohydrate counting,
nutrition labels, “my food plate”,
eating out, meal planning, heart
healthy eating, food substitution,
low fat diet, and DASH diet. We
also talked about types of exercise,
barriers to exercises, adopting an
exercise regimen, and exercise and
blood sugar. This lasted for 60
minutes
Patents asked questions, and they
were encouraged to share their
success stories with their peers in
the group. Patients who are doing
well with meeting their glycemic
goal were praised lead the
discussion and educate those who
were struggling with meeting their
glycemic targets. This lasted for 30
minutes
The session ended with each patient
setting a clear achievable goal as to
how they plan to improve their
diabetes management before next
meeting by writing the goal down
on a paper. The session was
adjourned until next 4 weeks
NP continued with the IMA, and
also reviewed the process outcomes
to make sure everything is on target.
Patients prepared and work on their
individual goals. NP prepared for
the booster session and reviewed the
education materials for that session

April 30th,
,2018/ Week 6

NP

•

April 27th, 2018
/Week 6
Booster session

MA

•

Patient
registration

Receptionist desk

Evaluation of # of patients still
attending the SMA sessions by
reviewing the SMA census.
Using EPIP EMR

RN

•

Group room

Using Welch Allyn Dinnamap

NP

•

Provider office

Going through each patient chart

Patients, NP,
RN, MA

•

Vital signs
including
weight and BP
Patient chart
review
Introduction and
Ice breaker
session

Group room

NP

•

Medical
management

Group room

Each staff introduced him/herself
and each patient did the same.
HIPPA reminder discussed during
this session
NP sequentially attended to each
patient in the group starting with
brief medical history first, followed
by brief physical examination and
finally, discussion of the lab results
including hemoglobin A1C and

Provider office
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WhenDate

Who

What

Where

How

RN

•

DSME

Group room

NP
RN

•

Peer support in
the group

Group room

NP

•

Visit conclusion
and goals

Group room

May 4th, 2018
/Week 7

Patients
NP

•
•
•

IMA
Patient goals
No SMA this
week

May11th, 2018/
Week 8

MA

•

Receptionist desk

RN

•

Group room

Using Welch Allyn Dinnamap

NP

•

Provider office

Going through each patient chart

Patients, NP,
RN, MA

•

Patient
registration
Vital signs
including
weight and BP
Patient chart
review
Introduction and
Ice breaker
session

medication management with the
participation of the group as peer
support. Each patients progress was
discussed in the group. Peers
provided support as necessary. This
lasted 5-10 minutes per patient
Presentation using, pictures,
handouts. Week 8 education will
focus on foot care. This education
was conducted by the clinic RN in
the group room using American
Diabetes Association (ADA)
professional resource handouts on
diabetic foot care. Proper foot care
for diabetics, diabetes foot ulcers,
when to visit podiatrist will be
discussed. This lasted for 60
minutes
Patents asked questions, and they
were encouraged to share their
success stories with their peers in
the group. Patients who are doing
well with meeting their glycemic
goal were praised and lead the
discussion and educate those who
were struggling with meeting their
glycemic targets. This lasted for 30
minutes
The session ended with each patient
setting a clear achievable goal as to
how they plan to improve their
diabetes management before next
meeting by writing the goal down
on a paper. The session was
adjourned until next 4 weeks
NP continued with the IMA and
reviewed the process outcomes to
make sure everything is on target.
Patients prepared and worked on
their individual goals.
Using EPIP EMR

Group room

NP

•

Medical
management

Group room

Each staff introduced him/herself
and each patient did the same.
HIPPA reminder will be discussed
during this session
NP sequentially attend to each
patient in the group starting with
brief medical history first, followed
by brief physical examination and
finally, discussion of the lab results
including hemoglobin A1C and
medication management with the

•
•
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Clinic
Home

WhenDate

Who

What

Where

NP

•

DSME

Group room

NP
RN

•

Peer support in
the group

Group room

NP

•

Visit conclusion

Group room
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How

participation of the group as peer
support. Each patients progress was
discussed in the group. Peers
provided support as necessary. This
lasted 5-10 minutes per patient
Presentation using, pictures,
handouts. Week 12 education
focused on behavioral modification.
NP utilized motivational
interviewing techniques, and topics
included readiness to change. This
lasted for 60 minutes
Patents asked questions, and they
were encouraged to share their
success stories with their peers in
the group. Patients who are doing
well with meeting their glycemic
goal were praised and lead the
discussion and educate those who
might be struggling with meeting
their glycemic targets. This lasted
for 30 minutes

The SMA session ended with the
same knowledge test that was
administered on the first day of the
implementation using University of
Michigan Diabetes Research
Training Center Diabetes
Knowledge Test. The results were
compiled and enter Excel sheet for
analysis. Each patient set a clear
achievable long-term goal as to how
they plan to improve their diabetes
management by writing the goal
down on a paper.
This session will conclude the SMA
sessions. All the patients were
thanked for their attendance.

Appendix F: Model for Evidence Based Practice Change

Step 1. Assess the need for
change in practice. Current
recommended national guideline
for A1C is below 7, current
average A1C in my clinic is 7.6.
Current recommended BMI is
below 25kg/m^2, and average
BMI in my clinic is 32kg/m^2.
This data lead to formulation of
the PICOT question

Step 2. Locate the best evidence.
Keywords retrieved from the
PICOT question and systematic
search conducted using the same
strategy in the CIHAHL, PubMed
and Cochrane.

Step 3. Critically analyze the
evidence. All the studies located
during the systematic search were
critically appraised using RCA/GAO
forms. The following evidences
were located after the review: 2 level
I, 5 Level II, 2 level III, 1 level IV, 2
level VI, and 1 level VII. Synthesis
table created based on these studies

Step 6. Integrate and maintain
change in practice.
Recommendations will be
presented to the stakeholders.
Based on the outcomes, standards
will be integrated into practice
and results disseminated

Step 5. Implement and evaluate
practice change. Patients will be
notified and intervention will begin.
Will evaluate processes, outcomes,
and cost. Then conclusions and
recommendations will be outlined.

Step 4. Design practice change.
Protocols which will include
implementation plan will be
created

Figure 1.1. Model for Evidence Based Practice Change

88

Appendix G: Health Belief Model

Sociopsychology
variables (Peer
support in SMA).
Structural
variable
(Knowledge gain
in SMA about
DM)

Perceived
Seriousness
(severity) of
disease.
(Uncontrolled
diabetes)

Perceived threat of
disease.
(Complications of
diabetes)

Cues to action
Collaboration/sharing
(Shared medical
Appointment (SMA)

Figure 1.2. Health Belief Model
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Perceived benefits of
preventive action
(Prevention of
diabetes
complications)

Self-Efficacy
(Health behavior
change,
Reduced Hgb A1C
Reduced BMI)

Appendix H: Logic Model

Assumptions
• ↑ Diabetes

knowledge will
promote
compliance
• Many diabetes
patients will
choose to attend
the SMA
because it will
benefit them
• Swift approval of
the project by
leadership

Inputs/Resources
•
•
•
•

•
•
•
•
•
•
•

Office Space
Staff
DVD player
Computer
with
internet
connection
Furniture
Teaching models
Dinamap
A1C Machine
Electronic scale
Television
Pamphlets

•

Data

•
•

tools
Stethoscope
Budget

collection

Activities

Outputs

Outcomes
•

Process Makers:
• Project protocol
completion by
12/2017
• IRB approval
letter completed
by 3/8/2018
• Team
meeting/educatio
n/mock SMA
by1/19/18
• Baseline data
collection by
3/23/2018
• Post intervention
data collected by
5/11/2018

•
•
•
•
•
•
•
•

•
•
•

# of SMA visits
Diabetes
education
Physical exam
Lab review
Health history
Peer interaction
Nutrition
education
Behavior
modification
education
Vital signs per
visit
Staff training
Data analysis

Short term goals: Pt
recognize that uncontrol
diabetes can lead to
serious complications
• Medium term goals:
More patients will
attend SMA visits
• Long term goals:
• Achieve A1C < 7
each patient
• Prevention of
complications
• ↑ Medication
knowledge
• ↑ Overall diabetes
knowledge
• ↑ Exercise levels
• ↓ BMI
• Adoption of healthy
eating

External Influences: Patient transportation difficulties, DSRIP grant availability, UTSW/Lifepath collaboration

Legend: ↑=increased; SMA=shared medical appointment; ↓=decreased

Figure 1.3. SMA Logic model
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Appendix I: Shared Medical Appointment Process Outcomes
Table I
SMA process outcomes with measurements

Estimated date of completion

Process Maker

Measurement

1/19/18

IRB proposal complete and submit
for review
Final IRB approval for the project
Project Protocol completion
Staff education on protocol
Project Implementation and baseline
data collection

Check Mark

3/8/18
12/15/17
1/19/18
3/23/18

4/30/18
4/30/18
5/11/18

Project milestone assessment to
check if datelines are being met
Number of patients who continue to
show for SMA sessions
Final data collection for A1C and
BMI
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Check Mark
Check Mark
Completion rate
A1C- Query from Epic
BMI- Query from Epic
Lipid values- Query from EPic
BP- Welch Allyn Dinnamap
Knowledge- Diabetes knowledge
test
Check mark
# of attendance per session
Intake data collection form

Appendix J: Diabetes Care Cost
Table J
Average diabetes care cost comparing clinic visit, hospital inpatient and emergency room visit
Values

Diabetes Management Clinic

Emergency Room

Inpatient

Encounters

1096

320

539

Avg Length of Stay

0.00

0.00

5.21

Avg of total Charges

$298

$2,682

$27,992

Avg Reimbursement

$167

$834

$11,144

92

Appendix K: SMA Implementation Budget
Table K
SMA implementation budget
SMA Project Budget
Expenses
Quantity
Unit Price
Total
Rent per month
3 $
2,083.00 $
6,250.00
Utility cost
3 $
667.00 $
2,000.00
Dinamap
1 $
2,600.00 $
2,600.00
A1C Machine
1 $
2,740.00 $
2,740.00
Computers
3 $
1,500.00 $
4,500.00
Electronic Scale
1 $
473.00 $
473.00
Paper
5 $
3.72 $
18.60
Monofilament
2 $
64.14 $
128.28
Otoscope
1 $
85.00 $
85.00
Stapler
2 $
27.99 $
27.99
Printer Ink
3 $
31.99 $
95.97
Printer/Scanner
1 $
99.99 $
99.99
Microalbumin machine
1 $
873.75 $
873.75
Microalbumin Strip
1 $
98.79 $
98.79
Otoscope probe box
1 $
33.56 $
33.56
NP Salary/Hr
22 $
55.00 $
1,210.00
RN Salary/Hr
22 $
33.00 $
726.00
CMA salary/Hr
22 $
14.00 $
308.00
Total
$
22,268.93
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Appendix L: Gantt Chart
Table L
Gantt showing SMA implementation timeline

SMA Implementation Gantt Chart
1/19

2/18

3/20

4/19

5/19

6/18

7/18

8/17

Staff education and Mock SMA
IRB Approval
SMA Begins Week 1
SMA Week 2
SMA Week 3
SMA Week 4
SMA Booster session 1
SMA Booster session 2
Data analysis
Dessimination
Sustainability
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9/16 10/16 11/15 12/15 1/14

2/13

3/15

4/14

5/14

6/13

7/13

8/12

Appendix M: SMA Results

Pre and Post Mean Outcome Values
140

128

125

120

100
84
77

80

60
35.45 33.63

40

20

7.11

7
52%

93%

0
HgA1C

Systolic BP

Diastolic BP
Pre Mean

BMI

Post Mean

Figure 1.4. Pre and post mean outcome SMA intervention values.
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Knowlwdge

SMA Pre and Post HbBA1c Values
12
10.2
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7.8
8

7.3

7.1

6.9
6.3

6.4

6

4

2

0
1001

1003

1004

PreHgBA1C

PostHgBA1C

Figure 1.5. SMA pre and post hemoglobin A1C values

96

1006

6.9

A1C values for participants who attended > 3 SMAs
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10.3
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8

7.1

6.9
6.4
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0
1003
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1006

PreHgBA1C

PostHgBA1C

Figure 1.6. A1C Values for Participants who attended >3 SMAs
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Effect of SMA on Patient Outcomes
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Figure 1.7. Effect of SMA on Patient Outcomes
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Total Cholesterol

Triglycerides

BMI

34

HbA1c
8
8

7.9

7.8

7.7

7.6

7.5

7.5

7.4

7.3

7.2
Pre-Mean

Post Mean

Figure 1.8. Pre and Post Mean A1C
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HbA1c

25%

38%

Pre-SMA # of patients with A1C ≤ 7

Post-SMA # of patients with A1C ≤ 7

Figure 1.9. Percent of patients at A1C goal post SMA intervention
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Hypertension

65%

88%

Pre-SMA # of patients with BP ≤ 140/90

Post-SMA # of patientas with BP ≤ 140/90

Figure 2.0. Percent of patients at blood pressure goal post SMA intervention
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Table M: SMA Clinical Outcomes, N=17
Outcome Measure

Pre-Mean

Post-Mean

p value (paired t-test)

HbA1c (%)

8.0

7.5

0.139

Systolic BP (mmHg)

133

126

0.145

Diastolic BP (mmHg)

81

75

0.043

LDL (mg/dl)

99

95

0.433

HDL (mg/dl)

47

48

0.470

Triglycerides (mg/dl)

221

222

0.985

Total Cholesterol (mg/dl)

190

183

0.337

BMI (kg/m2)

35

34

0.139
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